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The coordination chemistry of eight chelating heterocyclic ligands is described. These ligands 
all contain heterocyclic ring systems with bridgehead nitrogens, and have received little 
attention in the literature. The ring systems examined are, specifically, imidazo[1,2-
a]pyridine, imidazo[1,5-a]pyridine and triazolo[1,5-a]pyridine. 
 
The coordination complexes synthesised are mononuclear ruthenium(II) complexes, of the 
type [Ru(bpy)2(L)]
2+





UV-visible spectroscopy, cyclic voltammetry, and X-ray crystallography, in order to study 
their metal-ligand interactions. A total of six complexes were analysed by single crystal X-
ray diffractometry, and the resulting structures are described herein. 
 
In general, the inclusion of these ligands had the effect of raising the HOMO and lowering 
the LUMO, relative to the [Ru(bpy)3]
2+ 
complex. As a result, the complexes were easier to 









Coordination complexes have been of interest for hundreds of years (e.g. Alizarin 450 B.C., 
Prussian Blue 1704), however the theory behind these compounds was always a topic of 
debate. It wasn’t until Alfred Werner first proposed the octahedral geometry of cobalt(III) in 
1893
1,2
 that our understanding of coordination chemistry really began. Many different ligands 
have been examined over the years,
3,4
 and an important class of ligands in transition metal 
coordination chemistry has been the nitrogen containing aromatic heterocycles. Within this 
class, the two main groups of interest are the five-membered azoles (e.g. pyrrole) and the six 
membered azines (e.g. pyridine) (Fig 1.1). 
 
N
H    N  
Fig 1.1 Examples of aromatic nitrogen heterocycles. 
 
Azines and azoles have rather different electronic features, which can be explained by 
examining their resonance structures.
5
 Using pyridine as an example of a simple azine (Fig 
1.2), we can observe that in three of the five resonance contributors, there is a partial negative 
charge located on the nitrogen, while there is a partial positive charge located on the α/γ 
carbons of the ring. This resonance, in addition to the electron withdrawing nature of nitrogen 
(nitrogen being more electronegative than carbon), creates a permanent dipole towards the 
nitrogen. As such, pyridine and other related heterocycles have been described as electron 
poor, or π-deficient. Their π* orbitals are relatively low lying, and as such form stable 
complexes with transition metals; the ligand acts as a good π-acceptor, so the coordination 










Fig 1.2 Resonance contributors of pyridine. 
 
Conversely, examining the resonance structures of a simple azole (pyrrole, Fig 1.3) shows a 
partial positive charge centred on the nitrogen, with a partial negative charge on the carbons. 
This creates a permanent dipole away from the nitrogen. While the electron withdrawing 
nature of nitrogen will act in opposition to this dipole, the resonance effect is the more 
significant factor as the dipole is still observed to point away from nitrogen. Azoles are 
termed electron rich/π-excessive, and due to the nitrogen’s lone pair being part of the six-
electron aromatic system their binding potential can be increased by creating the anionic form 
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Fig 1.3 Resonance contributors of pyrrole. 
 
Pyridine is one of the most well-known nitrogen heterocycles, and its extensive study has 
seen interest in its coordination chemistry. Octahedral binding of six pyridines is typically 
disfavoured, as steric effects caused by the hydrogens α to the nitrogen hamper coordination. 
As such, octahedral complexes with coordinating counteranions M(py)4(anion)2 are 
common,
6
 with other geometries such as the square planar M(py)2(anion)2 having also been 
observed. It has been observed that the presence of large non-coordinating counterions, such 
as PF6
-
, can sometimes stabilise the octahedral M(py)6
2+ 
form. To force an octahedral 
arrangement, pyridine rings could be bound together, in a way that disfavours square planar 
binding and increases the binding potential through the chelate effect. In this way, the 




First reported in 1888,
7
 bpy has been the subject of many studies over the last 125 years, 
owing to its ability to form stable complexes with most transition metals
8
 and the interesting 
electrochemical, photochemical and photophysical properties
9,10
 that result. Bipyridine’s 
stability in complexes stems from a combination of effective back-bonding between the π-
deficient azines and the metal d-orbitals, and the stabilising effects of bidentate chelation.   
 
Of the possible transition metal complexes of bpy, tris(2,2'-bipyridine)ruthenium(II), 
[Ru(bpy)3]
2+ 
(Fig 1.4), has been the most studied, due to its many favourable properties as a 
coordination complex. First synthesised by Burstall
11
 in 1936, the first spectroscopic analysis 
carried out was a luminescence investigation by Paris and Brant in 1959.
12
 Extensive studies 
have revealed a raft of interesting properties. It absorbs light in the visible region of the 
electromagnetic spectrum, with a strong absorption at 452 nm (ε = 13600) due to metal-to-
ligand charge transfer, and has a comparatively long lived excited state (890 ns in acetonitrile 
at room temperature).
13
 The long lifetime is due to the first excited state existing as a triplet, 
while the ground state is a singlet; transition between these spin states is forbidden, and so 
will occur over an extended period of time. [Ru(bpy)3]
2+
 has interesting and reversible redox 
properties and stability; in acetonitrile solution vs a saturated calomel electrode (SCE) one 
reversible metal based oxidation is observed at +1.26 V, in addition to three reversible bpy-
based reductions (-1.33 V, -1.51 V and -1.79 V). Additionally, [Ru(bpy)3]
2+
 is both 
chemically photochemically stable. The combination of visible light absorption and a long 
lived excited state has made [Ru(bpy)3]
2+
 of interest in the production of photocatalysts, 

















The excited state of [Ru(bpy)3]
2+
 results from the transfer of an electron between the metal 
and ligands. Knowing this, we can tune the nature of the excited state by altering the ligands; 
by modifying or replacing one or more of the pyridine rings with either substituted 
derivatives or other heterocycles.
11
 The most pronounced results come from replacing the 
entire pyridine ring with another heterocycle, and as such many have been investigated.
15
 The 
simplest modifications involve substitution on the pyridine ring; 4,4′-dimethyl-2,2′-bipyridine 
is a popular modification made to ancillary bipyridine rings, as it helps to resolve the 
1
H 
NMR when the ligand being investigated contains pyridine. Other simple modifications 
involve the replacement of pyridine with a diazine or a benzo-fused azine,
11,15
 while more 
exotic modifications require replacement of bpy with a π-excessive azole.
15
 Previous work by 














 or by 
fusing the five-membered system with benzene (benzotriazole,
22
 benzothiazole and 
benzoxazole)
23











Fig 1.5 Examples of 1,2,3-thiadiazole and benzoxazole ligands. 
 
The present work examines the properties of a series of systems containing a bridgehead 
nitrogen; that is, pyridine fused imidazoles and triazoles (Fig 1.6), and their nature as 
bidentate chelating ligands for ruthenium(II). There has been very little study carried out on 
these classes of ligands, and even less on their complexes, as will be described in subsequent 
chapters. This thesis examines a series of [1,2-a]- and [1,5-a]-imidazopyridines and [1,5-a] 
triazolopyridines, bound either to pyridine or to itself to form a bidentate ligand. Chapters 2 




















Fig 1.6 Moieties examined in this work. 
 
Limited data exist for ruthenium(II) complexes of related ligands (Fig 1.7); Pradhan and 
Das
24
 examined a ruthenium(II) complex containing [3-(2-pyridyl)[1,2,4]triazolo[4,3-
a]pyridine for use in organic bistable memory applications, while our own group has 

















Fig 1.7 Related ligands with previously reported ruthenium complexes. 
 
The numbering of these ring systems can be the source of confusion. The ring systems are 
named first (as in Fig 1.8), while a separate numbering system is used to label substituents on 
the ring. The [X,Y-z] label is determined by where the 5-membered ring is fused to pyridine. 
The letter z is dictated by which bond of pyridine the 5-membered ring is fused across (Fig 
1.8a). The X and Y labels relate to which two atoms of the 5-membered ring are fused to the 
pyridine ring, and X is always the atom closest to the pyridyl nitrogen (or the nitrogen itself). 
































Fig 1.8 a) Labelling of the bonds of pyridine; b) example numbering of some fused 
systems ([1,2-a], [1,5-a] and [4,3-b]). 
 
Numbering for substituents follows a separate system. For my fused systems, it is typical to 
label such that the pyridyl nitrogen is the fourth atom. Using the first two structures of Fig 
1.8b as an example, atom 1 would be the atom labelled 3 and 4, respectively.   
 





with one- and two-dimensional correlation techniques carried out to assist in the assignment 




H homonuclear correlation 
spectroscopy (COSY) spectrum. This two-dimensional technique identifies spins that are 
coupled to each other, and from this we can determine which peaks belong to discrete ring 
systems. However, when peaks are not well separated, assignment by COSY can become 
difficult. In these instances, one-dimensional total correlation spectroscopy (1-D TOCSY) 
can be used. By this method we irradiate a single, well separated proton resonance, and 
observe the transfer of magnetisation as it moves to the other protons in the same spin 
system. An example from complex 9 is shown in Fig 1.9, where the doublet at 8.16 ppm is 
initially irradiated. This can be seen to first transfer magnetisation to the triplet at 7.92 ppm, 
then to the triplet at 7.10 ppm, and finally to the doublet at 7.53 ppm. By Trace V, the 
magnetisation has started to transfer back to the triplet at 7.10 ppm, and with more readings 
would be seen to return to the initial proton. To assign the 
13
C NMR spectrum, two-
dimensional heteronuclear correlations are performed. Heteronuclear single-quantum 
correlation spectroscopy (HSQC) detects the correlation between a hydrogen and the atom 
one bond away (i.e. the carbon it is bound to). Heteronuclear multiple-bond correlation 
spectroscopy (HMBC) detects the correlation between a hydrogen and the atoms two-to-four 
bonds away. This method is useful for locating quaternary carbons, as without bonds to 





Fig 1.9 Example of a 1-D TOCSY, performed on complex 9 at 8.16 ppm. 
 
Other analyses that will be used include mass spectroscopy, UV-Visible spectroscopy, cyclic 
voltammetry and X-ray diffraction.  
 
The specific mass spectroscopy technique used here was electrospray ionisation (ESI), time-
of-flight (TOF) mass spectroscopy (MS). ESI is known as a ‘soft ionisation’ technique, as it 
is able to produce ions with little in the way of fragmentation; this allows spectra to be more 
easily assigned. Ions are formed after the electrospray cone aerosolises the supporting liquid, 
when this volatile liquid evaporates. TOF is used to separate ions based on their mass-to 
charge ratio; as an ions relative velocity through an applied electric field is determined by this 
ratio, the time it takes for an ion to reach the detector can be used to calculate the relevant 
ratio. 
 
UV-Vis spectroscopy examines a compounds ability to absorb light in the ultraviolet-visible 
region of the electromagnetic spectrum. Light can promote an electron from the highest 
occupied molecular orbital (HOMO) to the lowest unoccupied molecular orbital (LUMO), 
and for ruthenium(II) complexes, absorption in the visible region generally occurs between a 
π bonding orbital (or an n non-bonding orbital) and a π* anti-bonding orbital. As the 







8.16 ppm 7.10 ppm
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longer wavelength requires less energy to promote this electron (i.e. it has a smaller HOMO-
LUMO energy gap).  
Cyclic voltammetry is used to examine the redox potentials and electrochemical reactions of 
a compound. By sweeping an applied potential, we can measure the resulting current and plot 
the results as a compound is oxidised or reduced. The current reaches a maximum as the 
potential approaches the redox potential of the analyte, and drops away as the concentration 
of the analyte remaining at the surface of the electrode decreases. Reversible redox couples 
can be observed when the potential is reversed; where the previously oxidised analyte is 
reduced, with the current of reverse polarity producing a peak with a similar shape to the 
forward scan.  
 
X-Ray diffraction is a crystallography technique whereby a single crystal is subjected to an 
X-ray beam. The resulting diffraction pattern contains a number of regularly spaced spots (or 
reflections), and a number of these patterns are recorded as the crystal is rotated in the source. 
We can subsequently build these patterns into a 3-D model, and the appropriate mathematical 
solutions can transform this into a 3-D electron density map. Using the relative intensities and 
our chemical knowledge of the sample crystal, these electron densities can be rationalised to 
individual atoms, and further into complete crystal structures. In this work we obtained 










In this chapter we examine a pair of imidazo[1,2-a]pyridine based heterocyclic ligands and 

















The compounds are, specifically, 2-(pyridin-2-yl)imidazo[1,2-a]pyridine (1) and 2,2'-










1     2 
Fig 2.2 
 
The parent imidazo[1,2-a]pyridine was first synthesised in 1925 by Tschitschibabin 
(Chichibabin),
26
 who used high temperatures (150-200°C) and a sealed tube to react 2-
aminopyridine with bromoacetaldehyde. A simpler method of synthesis was described by 
Mosby in 1961;
27
 it had been determined that heat was not necessary, and that chloro- or 
bromoacetaldehyde would react with 2-aminopyridine simply in the presence of sodium 
bicarbonate and alcohol solution. Over the years numerous other methods of synthesising 
10 
 
imidazo[1,2-a]pyridine and substituted derivatives have been examined, in an effort to attain 
a wider range of useable substituents with increased efficiency. Roe
28
 examined the reaction 
between imidazole and diketones, as well as a modified Tschitschibabin method using 
dioxane as the solvent. This modified method has been further adapted by other groups 
condensing 2-aminopyridines with α-halocarbonyls.
29
 Due to the limited number of α-
halocarbonyls available, a number of one-pot reactions have been developed in an effort to 
synthesise a wider array of derivatives. Investigated one-pot reactions include the reaction 
between aldehydes, isocyanides, and 2-aminopyridines,
30
 and metal catalysed three 
component coupling reactions between aldehydes, alkynes and 2-aminopyridines; transition 
metal salts containing copper
31-33
 are the most commonly used, however studies with other 




 have also been reported. 
 
The importance of determining effective methods of synthesising substituted imidazo[1,2-a] 
pyridines is linked to their biological activity. This fused heterocycle can be found within a 





 and antiulcer actions, among others. 







 (cardiotonic agent), minodronic acid 
(osteoporosis), zolimidine
41
 (antiulcer), saripidem and necopidem (sedative/anxiolytic). 
 
Despite the parent imidazo[1,2-a]pyridine unit having been first synthesised nearly a century 
ago, the ligands examined herein have been curiously ignored. Using SciFinder® to examine 
the literature, a search for compound 1 returns a total of three results; two papers, by 
 yra ski et al.
42
 and Chandra Mohan et al.,
43
 and a patent from Aries.
44
 A literature search 
for compound 2 yielded even fewer results, with this compound yet to be reported in any 
form. Because the few publications of these compounds focus solely on their synthesis, the 
complexation of these ligands has yet to be examined with any transition metals.  
 
 yra ski et al.
42
 examined a new synthesis of 2-substituted imidazo[1,2-a]pyridines based on 
a two-step reaction; an Ortoleva-King reaction, followed by cyclisation of the resulting 




 found that pyridinium salts 



















Scheme 2.1 An Ortoleva-King reaction, followed by cyclisation in base. 
 
Cyclisation of the pyridinium salt would occur quickly under basic conditions, and the 
resulting 2-imidazo[1,2-a]pyridine could be obtained in reasonable yield (~50%) with a 
variety of different R groups, depending on the methyl ketone used.  
 
Chandra Mohan et al.
43
 examined another new synthetic method, again reacting methyl 
ketones with 2-aminopyridine. In this work, instead of pre-activating the ketone with iodine, 
CuI/BF3·Et2O was used as a catalyst, with O2 as an oxidant. This method allowed them to 
synthesise a range of substituted imidazo[1,2-a]pyridines, in good yields. As an interesting 
aside, they successfully synthesised zolimidine; achieving in a single step what typically 
requires multiple steps. The proposed mechanism of this reaction, shown in Scheme 2.2, sees 
the 2-aminopyridine form an imine/enamine with the methyl ketone, before oxidative 
addition of CuI with O2 forms a Cu(III) complex. Reductive elimination regenerates the 






























The following sections will examine the synthesis of compounds 1 (synthesised via a 
literature procedure) and 2 (reaction of 1,4-dibromo-2,3-butanedione with 2-aminopyridine), 
and their subsequent complexation with bis(2,2'-bipyridine)ruthenium(II) dichloride to form 




C NMR, while the 
complexes were additionally examined by UV-visible spectroscopy, cyclic voltammetry and, 
where possible, crystal structures were obtained by X-ray diffraction.   
13 
 
2.2 Synthesis of Ligands 
 
Following the method detailed by  yra ski et al.
42
 2-(pyridin-2-yl)imidazo[1,2-a]pyridine (1) 
was synthesised (Scheme 2.3), and its presence was confirmed by 
1
H NMR. However, this 
spectrum also showed the presence of excess 2-aminopyridine. Separation of the product 
from the 2-aminopyridine proved problematic, with both eluting at a similar rate when 
subjected to column chromatography. A stock of 1 synthesised by a previous member of our 













Scheme 2.3 Synthesis of 2-(pyridin-2-yl)imidazo[1,2-a]pyridine (1). 
 
2,2'-Biimidazo[1,2-a]pyridine (2) was synthesised via the cyclocondensation of 2-
aminopyridine with 1,4-dibromo-2,3-butanedione, as shown in Scheme 2.4. However, as with 
1, separating the product from the excess 2-aminopyridine proved difficult, and as such very 










Scheme 2.4 Synthesis of 2,2'-biimidazo[1,2-a]pyridine (2). 
 
Other attempts at synthesising this compound involved adding sodium bicarbonate and heat 
to the reaction, however this did not produce any noticeable improvements; problematic 






C NMR spectra of ligands 1 and 2 were recorded in deuterated chloroform, 
with additional 
1
H NMR measurements recorded in deuterated acetonitrile to allow 
Coordination Induced Shift (CIS) analysis. Full proton and carbon assignments, made by a 
combination of 2-D experiments (COSY, HSQC, HMBC), can be found in the Experimental 
section (Chapter 6).  
14 
 
2.3 Synthesis and Characterisation of Complexes 
 
 
2.3.1 Synthesis of Bis(2,2'-bipyridine)[2-(pyridin-2-yl)imidazo[1,2-
a]pyridine]ruthenium(II) bis(hexafluorophosphate) (3) 
 
Ligand 1 was reacted with bis(2,2'-bipyridine)ruthenium(II) dichloride, [Ru(bpy)2Cl2],  in a 
1:1 ratio. The reactants were added to a 3:1 mixture of ethanol:water, and heated with stirring 
at reflux overnight. After workup, the product [Ru(bpy)2(1)](PF6)2, (3), was obtained in 


























Fig 2.3 Structure of the cation of complex 3. 
 
Complex 3 contains 25 aromatic protons; 16 from the ancillary bpy ligands, and 9 from 
ligand 1. The 
1
H NMR spectrum of the product displayed the expected 25 proton signals. The 
chemical shifts and Coordination Induced Shifts (CIS) for 1 and 3 are shown in Table 2.1. 
The 
1




H NMR Chemical Shifts
a
 and Coordination Induced Shifts
b
 of the coordinated 
imidazo[1,2-a]pyridine rings of 3 and the chemical shifts of 1. 
 H3 H4 H5 H6 H7 H3’ H4’ H5’ H6’ 
3 8.65 8.43 7.00 7.11 5.59 8.23 7.95 7.25 7.55 
1 8.30 8.34 6.85 7.24 7.54 8.15 7.82 7.27 8.58 
CIS +0.15 +0.09 +0.15 -0.13 -1.95 +0.08 +0.13 -0.02 -1.03 
a
 Solvent: deuterated acetonitrile (MeCN-d3). 
b




The proton with the chemical shift of 5.59 ppm is assigned to H7 of the ligand. The large 
upfield shift (CIS -1.95 ppm) is due to heavy shielding, caused by the ring-current anisotropy 
of the nearby pyridine ring. A combination of 2-D COSY and HMBC experiments was used 
to assign the rest of the ligand and the bpy protons. While it was possible to distinguish each 
of the ring systems with a COSY, this type of analysis does not allow us to determine which 
pyridine ring of bpy is cis, and which is trans to the ligand. The pyridine ring of the ligand is 
easy to determine, as its protons experience significant shifts relative to those of the bpy 
pyridines. The proton signals for 2-substituted pyridine rings could be expected to occur at 
similar positions. In 3, as each pyridine ring does not exist in an identical environment, the 
related protons will experience a small shift relative to each other. The resulting multiplet 
clusters occur at characteristic shifts, and are consistent across the range of ruthenium 
complexes examined in this work. There is a slight exception when examining H6 protons. 
Like the H7 proton of the ligand, these protons experience anisotropic shielding of varying 
magnitudes, depending on the other ligands present. One pyridine H6 appears to shift much 
further than the others; this can be assigned to the H6' proton of the ligand, as being part of 1 
will position it closer to neighbouring pyridine rings than if it were part of a bipyridine. This 





H NMR spectrum of [Ru(bpy)2(1)]
2+
, (3), in MeCN-d3. Red = 1 (H4-H7), Green 
= 1 (H3’-H6’), Blue = 2,2'-bipyridine. 
 
The UV-visible spectrum for complex 3 shows a λmax at 463 nm (Fig 2.5, Table 2.2). This 
metal-to-ligand charge-transfer (MLCT) band is at a longer wavelength (and thus a lower 
energy) than [Ru(bpy)3]
2+
 (452 nm), and it corresponds to the (M)d-(L)π* transition. The 
shoulder at 427 nm can likely be assigned to the (M)d-(bpy)π* transition, while the 
transitions at <326 nm are ligand centred. As the energy of MLCT bands have been shown to 
16 
 
indicate the relative size of the HOMO-LUMO energy gap,
11
 we can conclude that this gap is 
smaller in 3 than in [Ru(bpy)3]
2+
; 3 will be easier to excite than [Ru(bpy)3]
2+
 as a result. 
However, while easier to excite, a smaller molar absorption coefficient indicates that this 
complex does not absorb light as strongly as [Ru(bpy)3]
2+
. We can predict that the ΔEox-red1 
value for 3, obtained through electrochemical techniques, will be smaller than that of 
[Ru(bpy)3]
2+
, as the same molecular orbitals are involved ((M)d-(L)π*). 
 
 




Table 2.2 Absorption Maxima
a
 with Molar Absorption Coefficients
b
 and Redox 
Potentials
c
 of complex 3. 
Complex λmax (ε) Eox Ered1 Ered2 Ered3 ΔEox-red1 
[Ru(bpy)3]
2+
 452 (13600) +1.26 -1.33 -1.51 -1.79 2.59 
3 463 (8000) +0.99(78) -1.47(81) -1.69(83) - 2.46 
a








 In volts vs SCE. 
 
The cyclic voltammogram (CV) of complex 3 (Fig 2.6) shows a reversible oxidation at +0.99 
V, and two reversible reductions (Table 2.2). Complex 3 is easier to oxidise than [Ru(bpy)3]
2+
 
(+1.26 V), while it is noticeably harder to reduce; only two of three potential ligand based 
reduction peaks occurred within the solvent limit. Additionally, as these reductions are in 
agreement with the second and third reductions found in [Ru(bpy)3]
2+
, this indicates that if 
reduction of the coordinated 1 occurs, it must be past the solvent limit. With oxidation 
17 
 
occurring at the metal centre, the decrease in oxidation potential between [Ru(bpy)3]
2+ 
and 3 
indicates that the ruthenium atom in 3 is more electron rich than [Ru(bpy)3]
2+
. Likewise, the 
fact that 3 is harder to reduce than [Ru(bpy)3]
2+ 
indicates that 1 is a more electron rich ligand 
than bipyridine. Both of these features likely result from the π-excessive nature of the fused 
azole in 1 (compared with the π-deficient nature of bipyridine).
5
 As predicted, the ΔEox-red1 
value of 3 is smaller than that of [Ru(bpy)3]
2+




Fig 2.6 Cyclic Voltammogram of [Ru(bpy)2(1)]
2+
, (3), in volts vs silver wire. 
 
Crystals of complex 3 were grown by slow diffusion of petroleum ether into a solution of 
acetone containing the complex. X-Ray diffraction analysis was carried out on one of these 
crystals, and the resulting structure solved in the monoclinic space group C2/c. The 
asymmetric unit contains one full cation, two hexafluorophosphate counteranions and one 
and a half acetone solvate molecules. Twinning has led to disorder within this structure, with 
the ruthenium atom located in two locations in a 2:1 ratio, and an acetone solvent molecule 
being rotationally disordered. Although the ruthenium atom of the twinned structure is a 
major peak, those of its coordinated ligands are much weaker, to a degree that makes 
modelling this twin unfeasible. Figure 2.7 presents a perspective view of the complex cation, 






Fig 2.7 Perspective view of complex 3 cation, with partial labelling. Selected bond 
lengths (Å) and angles (°): Ru1-N1 2.123(7), Ru1-N3 2.083(6), Ru1-N4 1.970(6), Ru1-
N5 2.043(5), Ru1-N6 2.118(6), Ru1-N7 2.086(5), N1-Ru1-N3 78.9(3), N4-Ru1-N5 
80.8(2), N6-Ru1-N7 76.5(2), N1-C1 1.289(9), N1-C7 1.402(8), N2-C1 1.406(8), N2-C6 
1.388(12), C6-C7 1.373(11), N1-C1-N2 111.8(8), N1-C7-C6 108.6(8), N2-C6-C7 
107.3(7), C1-N1-C7 107.1(6), C1-N2-C6 105.3(6). 
 
While including the second ruthenium centre in the solved structure greatly improves the R-
factor (7.35% vs 12.44%), it has the effect of pushing the main atom slightly off centre. This 
leads to a slight skewing of bond lengths and angles between the ligands and the ruthenium 
centre. While this skewing is not obvious in the data between 1 and ruthenium (being a newly 
complexed ligand), the data for bpy is slightly more telling; these angles and bond lengths are 
fairly consistent across a range of complexes, as can be seen in the literature
47
 and later on in 
this work, and the range of values reported here indicate a clear discrepancy. 
 
The data relating the minor ruthenium atom Ru1A to the ligands often varies wildly each side 
of the expected values, and as such will not be examined here. This data, along with the 
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remaining distances and angles, is available from the Department of Chemistry, University of 
Canterbury.  
 
The bond length from ruthenium (Ru1) to the imidazo[1,2-a]pyridine nitrogen of 1 (N1) is 
2.123(7) Å, and to the pyridine nitrogen (N3) is 2.083(6) Å. Ruthenium-to-bipyridine bond 
lengths are typically fairly consistent; for example, Rillema et al.
47
 reported an average Ru-N 
bond length of 2.056(6) Å for [Ru(bpy)3]
2+
, while Steel et al. reported ranges of 2.051(3)-
2.061(3) Å and 2.048(3)-2.058(3) for the [Ru(bpy)2(L)]
2+







The bond lengths reported for 1 are thus longer than those expected of bipyridine, and this 
agrees with previously examined data. From the UV-vis and cyclic voltammetry data, we 
know that 1 is overall more electron rich than bipyridine, and as such does not experience the 
same level of stabilisation through back bonding as bpy. This, along with a greater steric 
bulk, would naturally lead to longer Ru-N bond lengths compared to bpy. Within 1, the 
imidazopyridine system is π-excessive, while the pyridine system is π-deficient; back 
bonding from the metal d-orbitals to the pyridines π-system results in the shorter length for 
Ru1-N3. The bite angle for N1-Ru1-N3, [78.9(3)°], is in agreement with related complexes. 
Both these bond lengths and angles are in reasonable agreement with those of the related 
complex 4, discussed later in this chapter. 
 
While the data regarding Ru1-1 conforms to predicted values, the data for Ru1-bpy is a little 
more variable. As previously discussed, the average Ru-bpy bond length tends to be around 
2.05 Å. The bipyridine ligand containing nitrogens N4 and N5 is located the closest to Ru1, 
with bond lengths of 1.970(6) Å and 2.043(5) Å, respectively; compare this to the N6/N7 
bipyridine, with bond lengths of 2.118(6) Å and 2.086(5) Å, respectively. This mixture of 
bipyridine ligands being closer and further away from the central ruthenium adds credence to 
the assumption that the major ruthenium atom in this solution is located slightly off centre. 
Interestingly, the average of these bond lengths is 2.054 Å. Bond lengths are not the only 
values that lie either side of the predicted values, with the bipyridine bite angles shifting in 
accordance with the bonds (N4/N5 80.8(2)° and N6/N7 76.5(2)°), either side of the bite angle 
in [Ru(bpy)3]
2+ 




When examining the 
1
H NMR of complex 3, the large upfield shift of the H7 proton was 
proposed to be due to ring-current anisotropic shielding of this proton by the pyridine ring 
that it points into. This can be seen in the crystal structure in Figure 2.7, with the proton of C2 
pointing towards the N6 containing ring. It is possible to approximate the distance from this 
proton to the centre of the pyridine ring (the position of hydrogens cannot be obtained from 
X-ray diffractometry, and are typically set to a fixed position in structural refinement), and 
from this we can get an indication of the relative distances involved. To emphasise the 
inherent inaccuracy of these calculations, values have been rounded to one decimal place. 
The distance between H7 and the N6 pyridine ring is calculated at ca. 2.9 Å. The H6’-N4 ring 
distance is ca. 3.1 Å, while the bpy H6 distances are as follows: to N3 ca. 3.3 Å, to N5 ca. 
3.4 Å, and to N7 ca. 3.2 Å. The distance from a bpy H6 to the fused pyridine of the ligand is 
the longest calculated, at a distance of ca. 4.0 Å. As this illustrates, H7 is predicted to be 
closest to the neighbouring pyridine ring, explaining the large upfield shift of H7. H6’ is 
predicted to be closer than the bpy H6 protons, explaining its larger upfield shift compared to 





2.3.2 Synthesis of Bis(2,2'-bipyridine)[2,2'-biimidazo[1,2-
a]pyridine]ruthenium(II) bis(hexafluorophosphate) (4) 
 
Ligand 2 was reacted with bis(2,2'-bipyridine)ruthenium(II) dichloride, [Ru(bpy)2Cl2],  in a 
1:1 ratio. The reactants were added to a small volume of ethylene glycol and irradiated in a 
microwave at 450 W; the reaction was monitored by thin-layer-chromatography (TLC) at 2 
minute intervals, for a total reaction time of 6 minutes. After precipitating the PF6
-
 salt 
(addition of aqueous KPF6), the product [Ru(bpy)2(2)](PF6)2, (4), was recrystallised by the 
addition of excess diethyl ether to the precipitate dissolved in the minimum amount of 




















Fig 2.8 Structure of the cation of complex 4 . 
 
Complex 4 contains a total of 26 aromatic protons. A total of 13 signals were seen in the 
1
H 
NMR spectrum, arising from the fact that 4 contains a two-fold rotational axis of symmetry. 
The chemical shifts and CIS values for 2 and 4 are shown in Table 2.3, and the 
1
H NMR 




H NMR Chemical Shifts
a
 and Coordination Induced Shifts
b
 of the coordinated 
imidazo[1,2-a]pyridine rings of 4 and the chemical shifts of 2. 
 H3 H4 H5 H6 H7 
4 8.43 8.42 6.95 7.06 5.48 
2 8.15 8.33 6.83 7.22 7.51 
CIS +0.28 +0.09 +0.12 -0.16 -2.03 
a
 Solvent: deuterated acetonitrile (MeCN-d3). 
b




As could be expected, the 
1
H NMR spectrum of 4 shares similarities to that of 3. The H7 
proton experienced a larger shift than in 3, which indicates this proton is located closer to the 
neighbouring pyridine ring (closer proximity leads to greater anisotropic shielding). A 2-D 





H NMR spectrum of [Ru(bpy)2(2)]
2+
, (4), in MeCN-d3. Red = 2, Blue/Green = bpy. 
 
The (M)d-(L)π* absorption band of complex 4 has shown a significant increase in 
wavelength, with a λmax of 480 nm (Fig 2.10, Table 2.4). This is almost 30 nm longer than 
that of [Ru(bpy)3]
2+
, and 20 nm longer than complex 3. As will be seen in later chapters, this 
is the longest wavelength for the (M)d-(L)π* absorption band reported in this work, and 
indicates that 4 has the lowest HOMO-LUMO energy gap of all the complexes examined. By 
substituting the pyridine ring containing ligand 1 with the double imidazo[1,2-a]pyridine 
ligand 2, we have significantly reduced the energy required to promote the complex from its 
ground state to its excited state. We have also reduced the molar absorption coefficient 
compared to [Ru(bpy)3]
2+
, meaning that while easier to excite, complex 4 does not absorb 








Table 2.4 Absorption Maxima
a
 with Molar Absorption Coefficients
b
 and Redox 
Potentials
c
 of complex 4. 
Complex λmax (ε) Eox Ered1 Ered2 Ered3 ΔEox-red1 
[Ru(bpy)3]
2+
 452 (13600) +1.26 -1.33 -1.51 -1.79 2.59 
4 480 (8100) +0.89(80) -1.50(70) -1.74(85) - 2.39 
a








 In volts vs SCE. 
 
The cyclic voltammogram of complex 4 (Fig 2.11) shows a reversible oxidation at +0.89 V, 
and two reversible reductions (Table 2.4). Complex 4 is slightly easier to oxidise than 3 
(+0.99 V), and is likewise harder to reduce. As was seen in the voltammogram of 3, the 
reduction peaks observed are in agreement with those of [Ru(bpy)3]
2+
, leading to the 
conclusion that the reduction of coordinated 2 occurs beyond the solvent limit. By replacing 
the π-deficient pyridine found in 1 with an additional π-excessive imidazo[1,2-a]pyridine, 
coordination with 2 has further increased the electron density found on the ruthenium atom 




 and 3, we have replaced one π-deficient pyridine ring with a 
π-excessive imidazo[1,2-a]pyridine system. This has the effect of increasing the electron 
density found on the ligand π-system, reducing the back bonding ability of the ligand, and 
thus increasing the electron density on the metal. Complex 4 contains two π-excessive 
24 
 




Fig 2.11 Cyclic Voltammogram of [Ru(bpy)2(2)]
2+
, (4), in volts vs silver wire. 
 
Crystals of complex 4 were grown by the slow diffusion of petroleum ether into a solution of 
the complex in acetone. One of the needle-like crystals formed was used for X-ray diffraction 
analysis. Solving in the monoclinic space group C2/c, the asymmetric unit of 4 contains a full 
cation, two hexafluorophosphate counteranions and one and a half acetone solvate molecules. 
Figure 2.12 shows a perspective view of the cation, with the counteranions and solvent 
molecules omitted for clarity.  
 
Unlike 3, the only disorder present here is solvent based, with the complete acetone molecule 
showing signs of disorder. The Ru-N bond lengths of the coordinating nitrogens of 2 [N1 
2.100(3) Å and N3 2.115(3) Å] are slightly longer than those of the bpy ligands [2.038(3) Å 
to 2.062(3) Å], and indicate that that 2 is a poorer electron donor than bipyridine.
48
 The bite 
angle of 2 is 77.834(11)°, compared with those of bpy [78.512(13)° and 78.963(11)°]. For 
both bond lengths and bite angles, the results are comparable to those of the structurally 
similar 2,2'-bibenzoxazole complex [Ru-L 2.104(5), 2.116(5) Å, 77.6(2)°; Ru-bpy 2.032(5)-
2.091(5) Å, 78.5(2)-78.6(2)°],
23
 and the results for bpy are in agreement with those 
previously reported for [Ru(bpy)3]
2+






Fig 2.12 Perspective view of 4, with partial labelling. Selected bond lengths (Å) and 
angles (°):  Ru1-N1 2.115(3), Ru1-N3 2.100(3), Ru1-N5 2.038(3), Ru1-N6 2.051(3), 
Ru1-N7 2.044(3), Ru1-N8 2.062(3), N1-Ru1-N3 77.8(11), N5-Ru1-N6 78.9(11), N7-
Ru1-N8 78.5(13), N1-C1 1.339(5), C1-N2 1.386(5), N2-C6 1.375(5), C6-C7 1.359(5), 
C7-N1 1.381(5), C7-C8 1.446(5), N1-C1-N2 109.1(3), C1-N2-C6 108.3(3), N2-C6-C7 
105.5(3), C6-C7-N1 110.9(3), N1-C7-C8 115.8(3). 
 
As was previously touched on, the structure of 4 shows obvious similarities with that of 
complex 3. The ruthenium-to-imidazopyridine bond lengths are consistent between the two 
complexes [2.100(3) Å and 2.115(3) Å vs 2.123(7) Å]. 
 
As illustrated with 3, we can view the cause of the large negative CIS value for H7 by 
examining the distances between protons and the centre of the ring into which they point. The 
distance of the H7 protons to their adjacent pyridine rings were calculated as ca. 2.7 Å and 
ca. 2.9 Å. These are comparable to, or just slightly shorter than, 3, which explains the slightly 
larger CIS value in 4 than in 3; as the H7 proton is closer to the centre of the pyridine ring, 
this proton experiences greater shielding and is thus shifted further upfield. The average bpy 
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H6 to ligand pyridine was ca. 3.9Å, and the average bpy H6 to bpy pyridine was ca. 3.2Å, 











In this chapter we examine a set of imidazo[1,5-a]pyridine based heterocyclic chelating 
ligands and their ruthenium complexes. The heterocyclic ring system and ring numbering are 
















The compounds examined are, specifically, 1-(pyridin-2-yl)imidazo[1,5-a]pyridine (5), 1,1'-
biimidazo[1,5-a]pyridine (6) (attempted synthesis), 3-(pyridin-2-yl)imidazo[1,5-a]pyridine 
(7) and 3,3'-biimidazo[1,5-a]pyridine (8) (Fig 3.2). 
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One of the first syntheses of imidazo[1,5-a]pyridine was reported by Bower and Ramage
49
 in 
1955. N-(2-Pyridinylmethyl)-formamide was refluxed in benzene with phosphoryl chloride, 
undergoing a Vilsmeier-type cyclisation to the imidazopyridine product. Further study was 
focused on various 1- and 3-substituted derivatives.  
 
While the above method still proves popular, various other synthetic pathways to 
imidazo[1,5-a]pyridine and its derivatives have been examined. Shibahara et al.
50,51
 examined 
a similar reaction using N-2-pyridylmethyl thioamides. In contrast to the method of Bower 
and Ramage, this synthesis could be carried out under reasonably mild conditions, with 
reactions starting at 0°C and being raised to room temperature over the course of the reaction. 
Iodine was used to mediate oxidative desulphurisation, which in turn led to cyclisation and an 
imidazopyridine product. Shibahara et al. have developed a number of other methods of 
synthesising imidazo[1,5-a]pyridines and their 1-/3-substituted derivatives. They examined a 
method of cyclising aryl aldehydes with aryl-2-methylpyridine using elemental sulphur as an 
oxidant,
52
 as well as a number of cross-coupling reactions to produce 3- and 1,3-substituted 
derivatives.
53,54
 Other methods based on an oxidative pathway include those of Bluhm et 
al.,
55,56
 Moulin et al.
57
 (thioacylation by Lawesson’s reagent, followed by ring closure by 
mercury(II) acetate), Ostermeie et al.
58
 (oxidation of 1,4-bis(2-pyridylmethyl)piperazine by 
iron(III) chloride), and Niyomura et al.
59
 (cyclisation of 2-(aminomethyl)pyridine with 
selenium dioxide). Methods involving an acid-mediated condensation include those of Wang 
et al.,
60,61
 Siddiqui et al.
62
 (condensation using ionic liquids), and Crawforth and Paoletti
63
 




Imidazo[1,5-a]pyridines are attractive molecules for use in a number of fields. They have 
been examined for potential application in organic light-emitting diodes (OLEDs)
64
 and 
organic thin-layer field effect transistors (FETs),
65
 and as possible precursors for N-
heterocyclic carbenes (NHCs).
66-68
 Like imidazo[1,2-a]pyridines, these compounds are 









Similar to 1, 5 has seen little study, with a literature search only finding two references; a 
1992 paper from Grigg et al.,
72
 and a 2002 paper from Hajos and Riedl.
73
 In comparison, the 
synthesis of 7 has been thoroughly examined, with 20 papers and patents detailing a variety 
of synthetic methods and modifications. Compounds 6 and 8 have never been reported. The 
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only reported transition metal complex of any of these ligands is a manganese(II) complex of 
7; Álvarez et al.
74
 used manganese(II) and ammonium cations to promote the dimerization of 




 examined an interesting reaction between 2,2'-dipyridyl ketone and α-amino 
acids, which led to a range of 1,3-disubstituted imidazo[1,5-a]pyridines (Scheme 3.1). Heated 
in methanol, the dipyridyl ketone reacts with an α-amino acid, and the resulting imine 
undergoes decarboxylation to form an azomethine ylide. This ylide subsequently undergoes 
1,5-electrocyclisation and aromatisation to give a 3-substituted-1-(2'-pyridyl)-imidazo[1,5-
a]pyridine. The moiety of the 3-substituent is dictated by the α-amino acid used, and can 
range from simple (R = H, glycine, leading to 5), to more complex (R = indole, tryptophan). 
Addition of a small amount of acetic acid was important to the reaction, as it had a notable 
catalytic effect; care must be taken though, as some amino acid moieties were found to 
undergo side-reactions when catalytic acid was present (e.g. histidine and tryptophan were 











































The earliest reported synthesis of compound 7 appears to be in 1971, published by 
Abushanab.
75
 While attempting to synthesise 2-(diethoxymethyl)-pyrazine (using pyrazine 
carboxaldehyde and methyl orthoformate, with ammonium chloride as a catalyst), an unusual 
by-product was obtained (10% yield). A combination of 
1
H NMR, mass spectrometry, and 
UV-visible spectroscopy strongly indicated that this by-product was 3-(2-
30 
 
pyrazinyl)imidazo[1,5-a]pyrazine. This reaction was further examined by reacting 2-pyridine 
carboxaldehyde with ammonium chloride and, despite a low yield (7%), the presence of 3-(2-
pyridinyl)imidazo[1,5-a]pyridine was confirmed by 
1





















In 2011, Huang et al.
76
 and Yamaguchi et al.
54
 examined a series of cross-coupling reactions, 
catalysed by palladium(II) acetate and [Pd(phen)2](PF6)2, respectively. In each example, 
imidazo[1,5-a]pyridine was reacted with a range of aryl halides (aryl bromides and aryl 
iodides, respectively), with C-3 arylation of the imidazopyridine occurring selectively in 
moderate to excellent yield (46-99%). While Huang et al. reported no arylation at the C-1 
carbon, Yamaguchi et al. found that under certain conditions this could occur, but only 
subsequent to the C-3 arylation (producing a diarylated product). Compound 7 was 
synthesised by both these methods, and was consistently one of the lowest reported yields 
(48-49%), due to the electron deficient nature of the pyridine ring.  
 
During this work, attempts were made at growing crystals of each complex that would be 
suitable for analysis by X-ray diffraction. Unfortunately, only one of the three complexes 
produced suitable crystals; 9 was crystallised by slow diffusion of diisopropyl ether into a 
solution of acetone containing the complex. A number of solvent systems were tested, 
including acetone or acetonitrile (with a drop of toluene) as the mother liquor, and diethyl 
ether, petroleum ether, diisopropyl ether, nitromethane, benzene or toluene as the diffusing 
solvent. Complex 10 grew some tiny crystals in acetone/diisopropyl ether, however these 
repeatedly failed to diffract when mounted on the diffractometer; the rest of the samples, 
failed to furnish single crystals.   
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3.2 Synthesis of Ligands 
 
Ligand 5 was synthesised as per the procedure detailed by Grigg et al.
72
 (Scheme 3.1, R = H). 
Di(2-pyridyl)ketone and glycine were added to methanol in a 1:1 ratio, along with a drop of 
glacial acetic acid. The reaction mixture was stirred at reflux for 24 hours, and monitored by 
TLC (silica, EtOAc) and 
1
H NMR. After column chromatography (silica, EtOAc), a final 
yield of 39% was obtained. 
 
Based on the synthesis of 5, an attempt at synthesising 6 was made by reacting 2,2'-pyridil 
with excess glycine (Scheme 3.3). After the reaction mixture was subjected to column 
chromatography, analysis of the fractions by 
1
H NMR and mass spectrometry indicated that 














MeOH + Acetic Acid
, 12hr
 
Scheme 3.3 Proposed synthesis of 6. 
 
A subsequent attempt at synthesising 6 followed a synthesis from Garino et al.,
77
 who had 
previously synthesised the 3-methyl derivative of 5. 2,2'-Pyridil and formaldehyde were 
added to a glacial acetic acid solution containing ammonium acetate. The reaction mixture 
was refluxed under nitrogen for 5 hours, and after cooling was neutralised by addition of 
sodium chloride and sodium bicarbonate. After extraction, 
1
H NMR and mass spectroscopy 
indicated that the desired product had not been produced.  
 




3.3 Synthesis and Characterisation of Complexes 
 
 
3.3.1 Synthesis of Bis(2,2'-bipyridine)[1-(pyridin-2-yl)imidazo[1,5-
a]pyridine]ruthenium(II) bis(hexafluorophosphate) (9) 
 
Ligand 5 was reacted with bis(2,2'-bipyridine)ruthenium(II) dichloride, [Ru(bpy)2Cl2], in a 
1:1 ratio. Added to a 3:1 mixture of ethanol:water, the reaction mixture was stirred at reflux 
overnight. After workup, the product [Ru(bpy)2(5)], (9), was obtained in excellent yield 























Fig 3.3 Structure of the cation of complex 9. 
 
Complex 9 contains a total of 25 aromatic protons; 16 from the two bpy ligands and 9 from 
ligand 5. 
 
Integration of the 
1
H NMR spectrum revealed a total of 25 signals. The chemical 
shifts and CIS values for 5 and 9 are shown in Table 3.1, and the 
1
H NMR spectrum of 9 is 




H NMR Chemical Shifts
a
 and Coordination Induced Shifts
b
 of the coordinated 
imidazo[1,2-a]pyridine rings of 9 and the chemical shifts of 5. 
 H3 H4 H5 H6 H7 H3’ H4’ H5’ H6’ 
9 7.87 8.10 6.97 7.36 8.10 8.16 7.92 7.10 7.53 
5 8.22 8.16 6.71 6.97 8.54 8.11 7.75 7.12 8.57 
CIS -0.35 -0.06 +0.26 +0.39 -0.44 +0.05 +0.17 -0.02 -1.04 
a
 Solvent: deuterated acetonitrile (MeCN-d3). 
b




Altering the shape of the ligand has significantly altered the 
1
H NMR spectrum. Unlike the 
imidazo[1,2-a]pyridine ligands (Chapter 2), the H7 proton of 9 is not in a position where it 
can experience serious anisotropic shielding; H6’ is now the proton that experiences the most 
shielding, with H3 is only slightly shielded by anisotropy. The upfield shift of H4 is likely 
due to a reduced through-space effect from the neighbouring bpy system. Because we no 
longer see H7 far upfield, we must look to other information to assign the different rings. The 
H6’ proton of 5 is the easiest to determine, as its shift to 7.53 ppm is characteristic of this 
proton. The other protons in this ring were determined by COSY analysis (Fig 3.5), and 
follow a similar shift pattern to those seen in related complexes. Determination of the 
imidazopyridine protons required a 1-D TOCSY analysis of the multiplet at 8.10 ppm (Fig 
3.6); this proved that both the H4 and H7 signals were found in this multiplet, as irradiation 





H NMR spectrum of [Ru(bpy)2(5)]
2+
, (9), in MeCN-d3. Red = 5 (H4-H7), Green = 5 
(H3’-H6’), Blue = bpy. 
 
 




Fig 3.6 1-D TOCSY of 9 in MeCN-d3. 
 
By examining the conformation of the free ligand and when it is chelated, we can propose 
two ways to potentially explain the larger negative CIS value for H7. The first is that this 
proton is being shielded. When chelating to ruthenium, the conformation that ligand 5 will 
have to adopt may place the H7 and H3’ protons in a close environment. To relieve the steric 
stress that would result, the two rings may be tilted relative to one another. This situation 
would lead to H4 and H3’ lying above the opposite ring’s pyridine system, resulting in each 
proton experiencing an anisotropic shielding effect. This situation seems unlikely however, as 
H3’ shows no upfield shift due to shielding. On the contrary, H3’ has been shifted downfield 
in this complex. The theory is further disproven upon examination of the crystal structure of 9 
(see below), in which the chelating 5 shows little in the way of distortion from planarity.  
 
The second explanation is that, rather than experiencing more shielding, the proton is 
experiencing less deshielding upon chelation.
78
 The H7 proton of the free ligand is at 8.54 
ppm (compare with the other imidazopyridine H7 signals of 7.51-7.65 ppm). This indicates 
that H7 is in fact deshielded, and the most likely cause for this is the nitrogen of the pyridine 
ring. In solution, to limit the steric interactions of H7 and H3’ discussed above, the 
conformation of the uncomplexed ligand will be such that the nitrogens are trans to each 















We might expect the H3’ proton to experience a similar deshielding effect to H7, however 
examining the shifts and CIS values indicate this is not the case. It is possible that the 
proximity of H7 to the pyridyl nitrogen versus that of H3’ to the imidazo nitrogen could 
explain the difference; a simple simulated 3-D model (created with ACD/Labs ChemSketch 
and 3D Viewer programs)
80,81
 of 5 in a planar conformation calculated the distances as ca. 
2.24 Å and ca. 2.67 Å respectively. 
 
In complex 9, the λmax corresponding to the (M)d-(L)π* transition occurs at 462 nm (Fig 3.8), 
almost identical to that found in the imidazo[1,2-a]pyridine complex 3, although with a 




) (Table 3.2). Similarly, the (M)d-
(bpy)π* transition occurs as a shoulder at 423 nm, while the ligand centred transitions occur 










Table 3.2 Absorption Maxima
a
 with Molar Absorption Coefficients
b
 and Redox 
Potentials
c
 of complex 9. 
Complex λmax (ε) Eox Ered1 Ered2 Ered3 ΔEox-red1 
[Ru(bpy)3]
2+
 452 (13600) +1.26 -1.33 -1.51 -1.79 2.59 
9 462 (10000) +1.09(90) -1.49(103) -1.69(100) - 2.58 
a








 In volts vs SCE. 
 
Minor impurities in the sample led to a less well defined cyclic voltammogram for 9, 
although this does not prevent us from examining the reversible nature of the peaks (Fig 3.9). 
As previously seen with the imidazo[1,2-a]pyridines (Chapter 2), the cyclic voltammogram 
contains three reversible peaks; one oxidation at a lower potential than [Ru(bpy)3]
2+
, and two 
bpy-based reductions, placing the reduction potential of 5 past the solvent limit. As such, 9 is 





Fig 3.9 Cyclic Voltammogram of [Ru(bpy)2(5)]
2+
, (9), in volts vs silver wire. 
 
Crystals suitable for X-ray analysis of 9 were grown by the slow diffusion of diisopropyl 
ether into a solution of 9 dissolved in acetone. Crystallising in the monoclinic space group 
P21/n, the asymmetric unit contains a full cation and two hexafluorophosphate counterions. 
Interestingly, this is the only structure reported in this work that solved without acetone 
solvate molecules being present. The cation is shown in Fig 3.10, with counterions omitted 
for clarity. Examining the coordination bonds between the central ruthenium atom and the 
ligands, the longest is that of Ru1-N1, from the metal to the pyridine ring of 5 [2.083(2) Å].  
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Conversely, the bond between ruthenium and the imidazo[1,5-a]pyridine ring is one of the 
shorter bonds [2.052(3) Å], and is very similar to those found in the ancillary bpy ligands 
[2.050(2) Å - 2.065(2) Å]. These results are contrary to what was observed in the previous 
chapter, where the ruthenium to imidazo bond was the longer, and the ruthenium to pyridine 
bond was shorter. This indicates that the imidazopyridine system is a good donor and may 
coordinate more strongly with ruthenium, and that the longer bond lengths in the previous 
chapter may have been the result of steric hindrance, caused by the position of the fused 
pyridine. A similar set of values can be observed in the ruthenium complex of the analogous 
[1,2,3]triazolopyridine;
25
 the triazolopyridine unit is located even closer to the central 
ruthenium [Ru-L(tri) 2.33(3) Å], as this system is more electron rich than the 
imidazopyridine. The rest of the bond lengths in this complex [Ru-L(py) 2.083(3) Å; Ru-bpy 
2.051(3)-2.061(3) Å] are consistent with those reported for 9. 
 
The bite angles (5 [78.40(10)°], bpy [78.47(10)°, 79.03(10)°]) are fairly regular, and those of 
bpy (along with the corresponding bond lengths) are in agreement with those previously 




As before, the chemical shifts present in the 
1
H NMR spectrum can be rationalised by 
calculating the distance between modelled hydrogens and the centre of the adjacent bpy 
pyridine systems. The distance between H3 and the N5 ring system is calculated at ca. 3.3 Å, 
while the distance from H4 to the N5 ring system is ca. 5.8 Å. The distance between H6’ and 





Fig 3.10 Perspective view of 9, with partial labelling. Selected bond lengths (Å) and 
angles (°): Ru1-N1 2.083(2), Ru1-N2 2.052(3), Ru1-N4 2.065(2), Ru1-N5 2.050(2), Ru1-
N6 2.056(2), Ru1-N7 2.051(3), N1-Ru1-N2 78.40(10), N4-Ru1-N5 79.03(10), N6-Ru1-
N7 78.47(10), N2-C6 1.378(4), C6-C7 1.390(4), N3-C7 1.382(4), N3-C12 1.374(4), N2-
C12 1.316(4), C5-C6 1.458(4), N2-C6-C7 110.0(3), C6-C7-N3 104.5(3), C7-N3-C12 








3.3.2 Synthesis of Bis(2,2'-bipyridine)[3-(pyridin-2-yl)imidazo[1,5-
a]pyridine]ruthenium(II) bis(hexafluorophosphate) (10) 
 
Ligand 7 was reacted with bis(2,2'-bipyridine)ruthenium(II) dichloride, [Ru(bpy)2Cl2],  in a 
1:1 ratio. A small volume of ethylene glycol was added to the reactants and irradiated in a 
microwave at 450 W, in 2 minute intervals for a total of 6 minutes. After precipitating the 
PF6
-
 salt (addition of aqueous KPF6), the product [Ru(bpy)2(7)](PF6)2, (10), was recrystallised 
by the addition of excess diethyl ether to the precipitate dissolved in the minimum amount of 
























Fig 3.11 Structure of the cation of complex 10. 
 
Complex 10 contains a total of 25 aromatic protons. The correct number of signals was 
confirmed by integration of the multiplets present in the 
1
H NMR spectrum. The chemical 
shifts and CIS values for 7 and 10 are shown in Table 3.3, and the 
1
H NMR spectrum of 10 is 




H NMR Chemical Shifts
a
 and Coordination Induced Shifts
b
 of the coordinated 
imidazo[1,2-a]pyridine rings of 10 and the chemical shifts of 7. 
 H1 H4 H5 H6 H7 H3’ H4’ H5’ H6’ 
10 7.03 8.83 7.18 7.24 7.63 8.31 8.02 7.21 7.70 
7 7.57 9.95 6.82 6.93 7.63 8.31 7.85 7.28 8.66 
CIS -0.54 -1.12 +0.36 +0.31 0 0 +0.17 -0.07 -0.96 
a
 Solvent: deuterated acetonitrile (MeCN-d3). 
b




In complex 10, both the H4 proton and the H6’ proton have experienced sizable upfield 
shifts, while H7 and H3’ have apparently seen no shift at all. As has been seen previously, the 
large negative  IS of H6’ is the result of anisotropic shielding, as is the negative shift of H1 
to a lesser degree.  
 
With the characteristic cluster of bpy H3 protons at ~8.5 ppm, and the upfield shifted H3’ 
signal at 8.31 ppm, the signal at 8.83 ppm was assigned to H4. COSY analysis was used to 





H NMR spectrum of [Ru(bpy)2(7)]
2+
, (10), in MeCN-d3. Red = 7, Green = 7 
(H3’-H6’), Blue = bpy. 
 
Changing the pyridine binding site of the imidazo[1,5-a]pyridine from C1 to C3 had some 
interesting effects on the proton NMR signals of the complex. The H7 signal of the free 
ligand 7 has been lowered in comparison to 5, while the H4 signal has been pushed well 
downfield. Both of these shifts are the result of deshielding effects in the free ligand, as 
discussed for 9. The H7 proton is no longer deshielded by the pyridyl nitrogen, with H4 now 
being the one deshielded. H4 is also moved downfield relative to H7 due to the 
electronegative nature of the neighbouring bridgehead nitrogen. Likewise, the H1 singlet is 
located further upfield than the H3 singlet of 9, as there is no longer a nitrogen adjacent to 
this proton.  
 
Both H7 and H3’ experience  IS values of 0. Examining the values of related sites in 
previous complexes (those of H3’ and H4 in 9 (the doublets not experiencing major shielding 
or deshielding effects)), correspondingly small CIS values are seen (-0.06 ppm to +0.09 
ppm). For H7, it is proposed that the 0 CIS value results from the cancellation of two effects; 
a downfield shift due to coordination, coupled with an upfield shift caused by a minor 




The  (M)d-(L)π* transition of complex 10 absorbs at very similar λmax wavelength than that 
of [Ru(bpy)3]
2+
; viz. 454 nm (Fig 3.13). This indicates that the HOMO-LUMO energy gap in 
10 is slightly smaller than that of [Ru(bpy)3]
2+
, while the extinction coefficient (11500) 
indicates that it is slightly harder to excite. The (M)d-(bpy)π* transition occurs at 424 nm, 
and the ligand based transitions occur at <300 nm (Table 3.4). 
 
 




Table 3.4 Absorption Maxima
a
 with Molar Absorption Coefficients
b
 and Redox 
Potentials
c
 of complex 10. 
Complex λmax (ε) Eox Ered1 Ered2 Ered3 ΔEox-red1 
[Ru(bpy)3]
2+
 452 (13600) +1.26 -1.33 -1.51 -1.79 2.59 
10 454 (11500) +1.10(84) -1.47(83) -1.67(88) - 2.57 
a








 In volts vs SCE. 
 
Following the trend, compared to [Ru(bpy)3]
2+ 
complex 10 is both easier to oxidise and 
harder to reduce, based on the reversible oxidation and reduction potentials shown in Figure 
3.14. Complex 10 appears to be slightly harder to oxidise than 9, however the inherent error 
associated with this measurement and equipment (±0.02 V) means their oxidation potentials 






Fig 3.14 Cyclic Voltammogram of [Ru(bpy)2(7)]
2+





3.3.3 Synthesis of Bis(2,2'-bipyridine)[3,3'-biimidazo[1,5-
a]pyridine]ruthenium(II) bis(hexafluorophosphate) (11) 
 
Ligand 8 was reacted with bis(2,2'-bipyridine)ruthenium(II) dichloride, [Ru(bpy)2Cl2],  in a 
1:1 ratio. The reactants were added to a small volume of ethylene glycol and irradiated in a 
microwave at 450 W, in 2 minute intervals for a total of 8 minutes. After precipitating the 
PF6
-
 salt (addition of aqueous KPF6), the product [Ru(bpy)2(8)](PF6)2, (11), was recrystallised 
by the addition of excess diethyl ether to the precipitate dissolved in the minimum amount of 
acetonitrile, and further subjected to column chromatography. Unfortunately, only a low yield 





















Fig 3.15 Structure of the cation of complex 11. 
 
Complex 11 contains 26 aromatic protons, and a two-fold rotational axis of symmetry; as 
such, from the 13 signals present in the spectrum, 8 signals result from the two bpy ligands, 
and 5 result from ligand 8. The chemical shifts and CIS values for 8 and 11 are shown in 
Table 3.5. The 
1




H NMR Chemical Shifts
a
 and Coordination Induced Shifts
b
 of the coordinated 
imidazo[1,2-a]pyridine rings of 11 and the chemical shifts of 8. 
 H1 H4 H5 H6 H7 
11 6.96 8.60 7.02 7.06 7.51 
8 7.62 9.78 6.84 6.93 7.65 
CIS -0.66 -1.18 +0.18 +0.13 -0.14 
a
 Solvent: deuterated acetonitrile (MeCN-d3). 
b




Like the comparison of 3 with 4, there are a lot of similarities between the spectra of 10 and 
11. The ligand signals occur at similar shifts, and were definitively assigned through the use 
of a COSY experiment. Many of the rationalisations made about 9 and 10 also apply here. 
The H1 and H7 signals have a more negative shift than 10, which indicate they are located 
closer to the neighbouring bipyridine ring; however, the lack of a crystal structure means this 





H NMR spectrum of [Ru(bpy)2(8)]
2+
, (11), in MeCN-d3. Red = 8, Blue/Green = bpy. 
 
In a similar manner to the red shift seen when moving from complex 3 to complex 4, we have 
likewise seen a red shift when moving from 10 to 11. Despite the absorption spectrum 
displaying a broad absorption band (Fig 3.17), we can observe the (M)d-(L)π* transition 
occurring at the longer wavelength of 469 nm. The (M)d-(bpy)π* transition occurs at 428 nm, 
similar to that seen in other complexes, and the ligand centred transitions occur at <315 nm. 
 
Table 3.6 Absorption Maxima
a
 with Molar Absorption Coefficients
b




Complex λmax (ε) Eox Ered1 Ered2 Ered3 ΔEox-red1 
[Ru(bpy)3]
2+
 452 (13600) +1.26 -1.33 -1.51 -1.79 2.59 
11 469 (9200) +0.88 -1.47 -1.70 - 2.35 
a

















Due to a shortage of sample, we could not use cyclic voltammetry to examine the 
electrochemistry of complex 11; instead, differential pulse voltammetry (DPV) was used. 
DPV is similar to linear sweep voltammetry, as each forward and reverse potential sweep is 
measured as a separate experiment. This technique is more sensitive that cyclic voltammetry, 
and while this means we can examine smaller sample sizes, it also means that minor 
impurities are more easily detected.  
 
The DPV of 11 displayed three oxidation peaks; two reversible (+879 mV and +1.27 V) and 
one quasi-reversible (+1.07 V). Similar to previous complexes, two reversible bpy-based one-
electron reduction peaks were observed (-1.47 V and -1.70 V). To determine which oxidation 
peak belongs to our complex of interest, we can examine the potentials alongside the 
absorption data. We know the oxidation of this type of complex is fully reversible, and as 
such the quasi-reversible Eox2 peak is an unlikely candidate. From previous examples we 
know that the values of ΔEox-red1 and λmax are linked; a longer wavelength gives a smaller ΔE 
value. With a λmax of 469 nm, 11 has a longer absorption wavelength than [Ru(bpy)3]
2+
, and 
so ΔEox-red1 must in turn be smaller than 2.59 V. The ΔE values for Eox1 and Eox3 are 2.35 V 
and 2.74 V, respectively, and as such the oxidation peak at +879 mV is attributed to 11. This 
means 11 is quite easy to oxidise, and indicates that ligand 8 is quite electron rich.  
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Eox3 has a very similar potential to that of [Ru(bpy)3]
2+
, however the lack of matching 
reduction peaks means that [Ru(bpy)3]
2+
 is unlikely to be the cause. Another theory as to the 
contributor to Eox3 is that, due to its steric nature, the ligand 8 may photodissociate and lead 
to the formation of other complexes. [Ru(bpy)2(CH3CN)2]
2+
 was proposed, however a search 















In this chapter we examine a pair of [1,2,4]triazolo[1,5-a]pyridine based heterocyclic ligands 


















The compounds examined are, specifically, 2-(pyridin-2-yl)[1,2,4]triazolo[1,5-a]pyridine 













12     13 
Fig 4.2 
 
Subsequent to their synthesis of imidazo[1,5-a]pyridine in 1955,
49
 Bower and Ramage 
published a follow-up paper in 1957,
83
 wherein they detailed the synthesis of 
[1,2,4]triazolo[1,5-a]pyridines, [1,2,3]triazolo[1,5-a]pyridines, and pyrazolo[1,5-a]pyridines. 
To synthesise the [1,2,4]triazolo[1,5-a]pyridines, N-2-pyridylamidines were boiled in acetic 
acid, with lead tetraacetate used to promote oxidative ring closure to the triazolopyridine 
product (Scheme 4.1). They were able to successfully synthesise a number of 2-substituted 
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derivatives (R = Me, Ph, p-tolyl), however they were unable to successfully synthesise the 
parent triazolopyridine (R = H), as the necessary amidine had yet to be synthesised. A further 
synthesis of the phenyl derivative followed in 1964, when Grenda et al.
84
 stumbled upon it 
while experimenting with azabenzimidazole synthesis. In a similar manner to Bower and 
Ramage, a N-2-pyridylamidine was cyclised to the final product, although on this occasion 


















The next attempt at synthesising this triazolopyridine was reported by Potts et al.
85
 in 1966, 
where they examined a number of different synthetic methods. After further experimenting 
with the method of Bower and Ramage, they turned their attention to the cyclisation of 1,2-
diaminopyridinium salts with organic acids (Scheme 4.2), and were successful in 
synthesising the parent [1,2,4]triazolo[1,5-a]pyridine using formic acid. Additionally, during 
their studies of the [1,2,4]triazolo[4,3-a]pyridine system,
86
 it was found that heating these 3-
substituted [4,3-a] systems in sodium hydroxide promoted a Dimroth rearrangement to the 2-
substituted [1,5-a] system.
87
 In this way, [1,2,4]triazolo[1,5-a]pyridine was synthesised by 




















Other synthetic methods include a 1,3-dipolar cycloaddition, where 1-aminopyridines react 
with nitriles to give 2-substituted triazolopyridines.
88,89
 Ueda and Nagasawa
90
  have reported 
a copper(I) catalysed reaction, occurring between 2-aminopyridines and aromatic nitriles, 
while Mammoliti et al.
91
 have examined a reaction between a series of thiadiazoles and 2-
chloro-3-nitropyridine (the expected [1,2,4]triazolo[4,3-a]pyridine was not seen, and has been 






Like the previous imidazopyridine systems, [1,2,4]triazolo[1,5-a]pyridines are of biological 
interest; while they themselves do not occur in nature, they share structural similarities with 
the important [1,2,4]triazole system. They have been examined as part of inhibitors of growth 
factor-β kinase receptors
92











There are currently no journal articles listed for either compound 12 or 13; the only literature 





 As such, no transition metal complexes have been reported. The 
English abstracts of these patents provide a rough outline as to the reactions that were carried 
out. Both Kiyogo and Tsukamoto utilised the 1,2-diaminopyridine method of Potts et al.,
85
 
and while Kiyogo used nitrile derivatives in a 1,3-dipolar cycloaddition, as per Okamoto et 
al.,
88
 Tsukamoto et al. used nitriles in a similar  method to that used by Ueda and Nagasawa
90
 
(without the copper(I) catalyst). In addition, Tsukamoto et al. reacted 2-cyanopyridine with 
an alkoxide to give (2-pyridyl)formiminoether; after reaction with 2-aminopyridine, the 





























4.2 Synthesis of Ligands 
 
 
Mixing of 2-aminopyridine with O-p-tolylsulphonyl hydroxylamine
102
 (TSH) formed the 
tosyl salt of 1,2-diaminopyridinium, which was subsequently cyclised with 2-
pyridinecarboxaldehyde at room temperature. After purification, the product, 2-(pyridin-2-


















Scheme 4.4 Synthesis of 2-(pyridin-2-yl)[1,2,4]triazolo[1,5-a]pyridine (12). 
 
2,2'-Bi[1,2,4]triazolo[1,5-a]pyridine (13) was synthesised in a similar manner. The 1,2-
diaminopyridinium salt was initially treated with sodium ethoxide, before diethyl oxalate was 
added and the mixture was brought to reflux for five hours. Dilution of the hot mixture with 























Scheme 4.5 Synthesis of 2,2'-bi[1,2,4]triazolo[1,5-a]pyridine (13). 
 





was carried out in deuterated chloroform, while additional 
1
H spectra were obtained in 
deuterated acetonitrile, to allow Coordination Induced Shifts (CIS) to be calculated. Full 
assignments of these compounds proton and carbon spectra, made by a combination of 2-D 




4.3 Synthesis and Characterisation of Complexes 
 
 




Complex 14 was synthesised on two separate occasions, by two different methods. This was 
necessitated by the need for a clean NMR, and the fact that 12 can bind in two different ways; 
through the N1 nitrogen (as shown in Fig 4.3), and through the N3 nitrogen. The first method, 
refluxing overnight in ethanol, led to a mixture of isomers which proved difficult to separate. 
The second method, a microwave synthesis, was carried out in an attempt to quickly form a 
single product, and efforts were taken to reduce the amount of light the resulting solutions 
were exposed to, as dissociation and isomerism are often light induced processes.  
The first method reacted a 1:1 ratio of ligand 12 and bis(2,2'-bipyridine)ruthenium(II) 
dichloride, [Ru(bpy)2Cl2]. The reaction was carried out in a 3:1 mixture of ethanol:water, 
with stirring at reflux overnight. After standard workup, the product [Ru(bpy)2(12)](PF6)2, 
(14), was obtained in excellent yield (87%) 
For the second synthesis, ligand 12 was reacted in a 1:1 ratio with [Ru(bpy)2Cl2] in a small 
volume of ethylene glycol. The solution was irradiated at 450 W, with monitoring by TLC in 
2 minute intervals for a total of 8 minutes. After the addition of aqueous KPF6, the product 
was recrystallised by the addition of excess diethyl ether to the complex dissolved in the 


























Analysing the first sample of 14 by 
1
H NMR was problematic as ligand 12 can bind to 
ruthenium through either the N1 or the N3 nitrogen, and the two isomeric forms proved 
difficult to separate. Worse still, extended exposure of solutions of the complex to light saw 
the initial 3:1 ratio evolve to roughly 1:1 (observed by the change in integral values over a 
number of weeks).  The second (microwave) sample presented a much cleaner spectrum, with 
only one isomer being prominently observed. This isomer was the minor product of the first 
reaction, and is thought to be the thermodynamic product (The high energies involved in 
microwave synthesis often lead to the thermodynamic product being produced over the 
kinetic. Further supporting this reasoning is the observation that the major isomer of method 
1 began to equilibrate with the minor isomer after periods of extended exposure to light.).  
 
Complex 14 contains a total of 24 aromatic protons; 16 from the two bpy ligands and 8 from 
ligand 12. The
 1
H NMR spectrum of the product displayed all 24 signals, determined by 
analysing the integral values of the various multiplets. The chemical shifts and CIS values for 
12 and 14 are shown in Table 4.1, and the 
1




H NMR Chemical Shifts
a
 and Coordination Induced Shifts
b
 of the coordinated 
imidazolo[1,2-a]pyridine rings of 14 and the chemical shifts of 12. 
 H4 H5 H6 H7 H3’ H4’ H5’ H6’ 
14 8.83 7.31 7.53 5.88 8.50 8.11 7.45 7.68 
12 8.69 7.07 7.56 7.82 8.36 7.89 7.41 8.83 
CIS +0.14 +0.24 -0.03 -1.94 +0.14 +0.22 +0.04 -1.15 
a
 Solvent: deuterated acetonitrile (MeCN-d3). 
b




H NMR of the microwave sample, peaks were assigned by a combination of COSY, 
HSQC and HMBC experiments, and the isomeric form present (chelating through N1) was 
determined by crystal structure analysis, along with comparisons to the 
1
H NMR spectra of 
analogous complexes (3 and 15). The key chemical shift to assign is the doublet present far 
upfield at 5.88 ppm. Like previous examples, this upfield shift is due to anisotropic shielding 
of a ligand proton by an ancillary bpy ring. When this shift is assigned to the H7 proton, the 
resulting CIS values for H7 and H4 are comparable to those of 3 (-1.95 and +0.09 ppm, 
respectively). In comparison, assigning 5.88 ppm to the H4 proton leads to some dramatic 
CIS values. Values of +1.01 ppm (H7) and -2.81 ppm (H4) are much larger than any 
previously examined, and are hard to rationalise when more agreeable values are available. 
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As such, the shift at 5.88 ppm is assigned to H7, and so ligand 12 must be binding through 





H NMR spectrum of [Ru(bpy)2(12)]
2+
, (14), in MeCN-d3. Red = 12 (H4-H7), 
Green = 12 (H3’-H6’), Blue = bpy. 
 
The (M)d-(L)π* absorption band of complex 14 occurs at a λmax of 454 nm (Fig 4.5, Table 
4.2). This wavelength is slightly longer than that of [Ru(bpy)3]
2+
, which in turn indicates the 
HOMO-LUMO gap of 14 is slightly smaller. The extinction coefficient indicates that this 
complex absorbs light more strongly than the imidazo[1,2-a]pyridines, but not quite as 
strongly as  [Ru(bpy)3]
2+
 and the imidazo[1,5-a]pyridines.  
 
 







Table 4.2 Absorption Maxima
a
 with Molar Absorption Coefficients
b
 and Redox 
Potentials
c
 of complex 14. 
Complex λmax (ε) Eox Ered1 Ered2 Ered3 ΔEox-red1 
[Ru(bpy)3]
2+
 452 (13600) +1.26 -1.33 -1.51 -1.79 2.59 
14 454 (9800) +1.13(90) -1.45(90) - - 2.58 
a








 In volts vs SCE. 
 
An unusual result was obtained when 14 was examined by cyclic voltammetry (Fig 4.6). In 
the previously examined cyclic voltammograms, the lower solvent limit of the acetonitrile 
solution occurred around -1.8 V (± 100 mV or so). However, for a sample of 14 the solvent 
limit occurred around -1.5 V, and as such only one reduction peak can be fully observed (the 
second peak can be seen to start forming immediately before the solvent limit). The solution 
was further degassed with nitrogen to determine whether oxygen was the cause; unfortunately 
this was not the case. The shift in the solvent limit is reflected in a shift of the peaks; the 
ferrocene reference peak of 14 occurs at 460 mV, compared with that of 3 (443 mV, limit ~-
1.75V) and 10 (273 mV, limit ~-2 V). This illustrates the importance of recording a reference 
peak such as ferrocene, as discrepancies in the measured potential can be corrected to a 
standard value. While the solvent limit has prevented us from observing the second and third 
reductions, the oxidation and reduction values obtained after correction vs a saturated 




) = 310 mV]) are within the expected range of values. The 
cyclic voltammogram of complex 14 shows a reversible oxidation at +1.13 V, and a single 
reversible bpy-based reduction. Complex 14 is easier to oxidise than [Ru(bpy)3]
2+
, however it 





Fig 4.6 Cyclic Voltammogram of [Ru(bpy)2(12)]
2+
, (14), in volts vs silver wire. 
 
Crystals of complex 14 were grown by slow diffusion of petroleum ether into a solution of 
acetone containing the complex. X-Ray diffraction was used to examine one of these crystals, 
and the resulting structure solved in the triclinic space group P-1. Contained in the 
asymmetric unit are one full cation, two hexafluorophosphate counteranions, and two acetone 
solvate molecules. Figure 4.7 shows a perspective view of the cation, with solvent and 
counteranions omitted for clarity. Ligand 12 has the potential to bind through either the N1 
nitrogen or the N2 nitrogen (N3 in the previous NMR numbering). The mode of binding 
present here is through the N1 nitrogen, and was rationalised by a number of factors. The 
structure modelled in Figure 4.7 has the lowest R1 value, in addition to the most regular 
thermal parameters (when compared to the structure obtained by swapping the N3 and C1 
atoms). As discussed previously, this structure is also in the best agreement with the observed 
1
H NMR data.  
 
With a bond length of [2.077(4) Å] between the ruthenium centre (Ru1) and the triazole 
nitrogen of 12 (N1), and a distance of [2.098(4) Å] between Ru1 and the pyridyl nitrogen 
(N3), we have seen an interesting shift between 3 and 14. Where the pyridyl ring was once 
located closest to the metal centre, now the triazolopyridine is the closer of the two rings. 
This indicates that the triazole moiety associates more strongly with the metal centre, perhaps 
through greater donation from the electron rich triazole. The bite angle of ligand 12 
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[77.85(15)°] is in good agreement with previously reported values, as are the bite angles of 
the ancillary bpy ligands [78.97(17)°, 78.83(15)°]. 
 
 
Fig 4.7 Perspective view of 14, with partial labelling. Selected bond lengths (Å) and 
angles (°):  Ru1-N1 2.077(4), Ru1-N4 2.098(4), Ru1-N5 2.047(4), Ru1-N6 2.065(4), 
Ru1-N7 2.056(4), Ru1-N8 2.055(4), N1-Ru1-N4 77.85(15), N5-Ru1-N6 78.97(17), N7-
Ru1-N8 78.83(15), N1-C1 1.344(6), C1-N3 1.383(7), N3-N2 1.349(6), N2-C6 1.327(6), 
C6-N1 1.366(6), C6-C7 1.449(7), N1-C1-N3 108.4(4), C1-N3-N2 110.2(4), N3-N2-C6 






4.3.2 Synthesis of Bis(2,2'-bipyridine)[2,2'-bi[1,2,4]triazolo[1,5-
a]pyridine]ruthenium(II) bis(hexafluorophosphate) (15) 
 
A 1:1 mixture of 2,2'-bi[1,2,4]triazolo[1,5-a]pyridine and Ru(bpy)2Cl2 was added to a small 
volume of ethylene glycol and reacted via microwave irradiation (450 w, 3x2 minutes, with 
monitoring by TLC). After cooling, the PF6
-
 salt was precipitated (addition of aqueous KPF6) 
and recrystallised by the addition of excess diethyl ether to the complex dissolved in the 
minimum volume of acetonitrile, to give the pure product [Ru(bpy)2(13)](PF6)2, (15), in 




















Fig 4.8 Structure of the cation of complex 15. 
 
Complex 15 contains a two-fold rotational axis of symmetry, and as such the 24 aromatic 
protons were seen as 12 proton signals; 8 from the two bpy ligands and 4 from ligand 13. The 




H NMR Chemical Shifts
a
 and Coordination Induced Shifts
b
 of the coordinated 
imidazolo[1,2-a]pyridine rings of 15 and the chemical shifts of 13. 
 H4 H5 H6 H7 
15 8.87 7.34 7.56 5.80 
13 8.79 7.19 7.67 7.84 
CIS +0.08 +0.23 -0.11 -2.04 
a
 Solvent: deuterated acetonitrile (MeCN-d3). 
b
  IS = (δcomplex - δligand). 
 
Like 12, ligand 13 can potentially bind to ruthenium through either the N1 or the N3 
nitrogens. To compound matters, 13 could thus bind to give any one of three isomers. As 
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such, obtaining a clean, single isomer (
1
H NMR) after minor purification was an excellent 
result. Proton signals were assigned by a COSY experiment, and the isomeric form (chelating 
through both N1 nitrogens) was assigned through the same rationalisation as for complex 14; 
by examining and comparing the shifts and their resulting CIS values, and confirmed by X-
ray diffraction analysis. 
Figure 4.9 shows a clean, single isomer spectrum, with the bpy peaks in their characteristic 
positions and the peaks of 13 in a similar arrangement to previous complexes (Chapter 2). As 
has been discussed previously, anisotropic shielding leads to the large negative CIS value for 





H NMR spectrum of [Ru(bpy)2(13)]
2+
, (15), in MeCN-d3. Red = 13, Blue/Green 
= bpy. 
 
By replacing the pyridine moiety of 12 with the additional triazolopyridine of 13, we have 
seen a red shift in absorbance (λmax = 461 nm) (Fig 4.10). This places the HOMO-LUMO 
energy gap of the (M)d-(L)π* transition lower than both [Ru(bpy)3]
2+
 and 14. This is also 
illustrated in the cyclic voltammogram of complex 15; a ΔEox-red1 value of +2.57 V is slightly 
lower than the comparative value of [Ru(bpy)3]
2+ 
(+2.59 V). Figure 4.11 and Table 4.4 show 
the single reversible oxidation peak (+1.11 V), and the two reversible bpy-based reductions 
of this complex. Complex 15 is slightly harder to oxidise than the analogous imidazo[1,2-
a]pyridines, and similarly hard to reduce. This indicates that, while more electron rich than 
pyridine, the triazolopyridine moiety may be less electron rich than the imidazo[1,2-
a]pyridines; alternately, as was seen in the crystal structure of 14, the triazolopyridine moiety 









Table 4.4 Absorption Maxima
a
 with Molar Absorption Coefficients
b
 and Redox 
Potentials
c
 of complex 15. 
Complex λmax (ε) Eox Ered1 Ered2 Ered3 ΔEox-red1 
[Ru(bpy)3]
2+
 452 (13600) +1.26 -1.33 -1.51 -1.79 2.59 
15 461 (8600) +1.11(83) -1.46(81) -1.68(89) - 2.57 
a








 In volts vs SCE. 
 
Fig 4.11 Cyclic Voltammogram of [Ru(bpy)2(13)]
2+




Crystals of complex 15 were grown by slow diffusion of petroleum ether into a solution of 
the complex in acetone. One of the needle-like crystals formed was used for X-ray diffraction 
analysis. Crystallising in the monoclinic space group P21/n, the asymmetric unit of 15 
contains a full cation, two hexafluorophosphate counteranions and two acetone solvate 
molecules. Figure 4.12 shows a perspective view of the cation, with the counteranions and 
solvate molecules omitted for clarity. The crystal structure of 15 shows both halves of ligand 
13 coordinating through the N1 nitrogen. Like 14, this structure gave the lowest R1 factor 
with the most regular thermal parameters, and is in best agreement with the observed 
1
H 
NMR data. The Ru-N bond lengths of the coordinating nitrogens of 13 [2.093(3) Å and 
2.109(3) Å] are slightly longer than those of the bpy ligands [2.046(3) Å to 2.069(3) Å], and 
comparable to those of the imidazolo[1,2-a]pyridine analogue (4, 2.100(3) Å and 2.115(3) 
Å). They are also slightly longer than the equivalent bond in 14 [2.059(13) Å], probably for 
steric reasons. The bite angle of 13 is 77.14(12)°, compared with those of bpy [79.03(13)° 
and 79.71(13)°]. For both bond lengths and bite angles, the results for bpy are in agreement 
with those previously reported for [Ru(bpy)3]
2+
 in the literature [2.056(6) Å, 78.7(2)°, 
79.4(2)°].
47
 The large CIS value for H7 can be further explained by examining the distances 
between protons and the centre of the ring into which they point. The average distance of the 
H7 proton to the adjacent pyridine ring was calculated as ca. 3.04Å, while the average bpy 
H6 to ligand pyridine was ca. 3.83Å, and the average bpy H6 to bpy pyridine was ca. 3.17Å. 
As the H7 proton is much closer to the centre of the pyridine ring, this proton experiences 





Fig 4.12 Perspective view of 15, with partial labelling. Selected bond lengths (Å) and 
angles (°):  Ru1-N1 2.093(3), Ru1-N4 2.109(3), Ru1-N7 2.056(3), Ru1-N8 2.046(3), 
Ru1-N9 2.055(3), Ru1-N10 2.069(3), N1-Ru1-N4 77.14(12), N7-Ru1-N8 79.71(13), N9-
Ru1-N10 79.03(13), N1-C1 1.347(5), C1-N2 1.372(5), N2-N3 1.372(5), N3-C6 1.321(5), 
C6-N1 1.359(5), C6-C7 1.452(5), N1-C1-N2 107.7(3), C1-N2-N3 111.0(3), N2-N3-C6 
101.6(3), N3-C6-N1 115.9(3), N1-C6-C7 115.1(3). 
 
The preceding data on complex 15 all comes from a pure sample. The first sample 
synthesised was not so pure, for an interesting reason. First synthesised by refluxing in 
aqueous conditions, the 
1
H NMR of this product indicated there were two compounds 
present, in an 8:1 ratio. Initially, it was assumed that this was an isomeric form, with ligand 
13 binding through one or both of the N3 nitrogens. The mass spectrum of this product 
showed three ruthenium based peaks; the product 15 cation at m/z 325.0609, some 
[Ru(bpy)3]
2+
 impurity at m/z 285.0544, and an additional peak at m/z 365.0670. The identity 
of this additional peak was later revealed when crystals were grown. After a number of failed 
attempts to find and analyse a suitable crystal (consistently running into unit cell errors), a 






(16) (Fig 4.13). 
 
 
Fig 4.13 Perspective view of 16, with partial labelling. Selected bond lengths (Å) and 
angles (°):  Ru1-N1 2.118(5), Ru1-N4 2.096(5), Ru1-N7 2.035(5), N1-Ru1-N4 76.7(2), 
N7-Ru1-N7 79.1(3), N1-C1 1.360(7), C1-N3 1.355(9), N3-N2 1.393(9), N2-C6 1.324(9), 
C6-N1 1.331(8), C6-C7 1.449(10), N1-C1-N3 107.0(6), C1-N3-N2 111.4(5), N3-N2-C6 
100.3(6), N2-C6-N1 116.9(6), C6-N1-C1 104.3(5). 
 
Solving in the monoclinic space group of C2/c, the asymmetric unit of 16 contains half of a 
full cation, and one hexafluorophosphate counteranion. The structure also contained some 
amount of diffuse, poorly ordered solvate, which was removed using a solvent mask. Figure 
4.13 shows a perspective view of the full cation, with counteranions omitted for clarity. Once 
again, the ligand binds exclusively through the N1 nitrogen, as this gave the lowest R1 value 
and the most regular thermal parameters. The bond lengths [2.118(5) and 2.096(5) Å] and 
bite angle [76.7(2)°] between the coordinating nitrogens of 13 and the central ruthenium are 
in excellent agreement with the values reported for 15 ( [2.093(3) Å] and [2.109(3) Å], 
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[77.14(12)°]). The values for the ancillary bpy ligands are also in good agreement (16 
[2.035(5) Å, 79.1(3)°], 15 [2.046(3)-2.069(3) Å, 79.03(13)°, 79.71(13)°]). 
 
This was a most unusual result, and it is currently unknown why this product forms. 
Exposure to light and a light mediated exchange of ligands was proposed as a potential cause. 
To test the effect of light on this reaction, a sample 15 was prepared in the dark, in aqueous 
reflux conditions.  are was taken to limit the subsequent workup’s exposure to light, and the 
end result saw the presence of 16 in the mass spectrum. This would indicate there is some 
other process involved, either instead of or in addition to photoexcitation. Ligand 13 is not 
the only ligand that this occurs with either. When examining the aqueous complexation of 7 
and 8, peaks were also observed of their respective bis-ligand products. No bis-ligand 
complex was seen in the products of 12, 1, 2, and 5. It is possible that the resulting complexes 









This thesis described the synthesis and analysis of a number of little-studied heterocyclic 
chelating ligands, and offers a first look at the structure and properties of their ruthenium(II) 
complexes. The heterocycles examined all contain bridgehead nitrogens, and feature fused 
pyridine/imidazole or pyridine/triazole functionalities. All ligands were synthesised either 
using a new procedure or a literature preparation.  
 
Ruthenium(II) complexes formed were of the type [Ru(bpy)2(L)]
2+
, as this allowed us to 
compare their properties with the well-studied [Ru(bpy)3]
2+ 
complex. Complexes were 
formed by reacting ligands with Ru(bpy)2Cl2, either by aqueous reflux or microwave 
methods, with purification involving a mixture of column chromatography and 
recrystallisation. Each complex was analysed by a combination of multinuclear NMR, UV-
visible absorption spectroscopy and cyclic voltammetry, and a number of trends were 
observed. 
 
Coordination induced shifts (CIS) were used to examine the effect of coordination on the 
ligand; these values originate from the difference between the chemical shifts of the 
complexed ligand, and those of the free ligand. Small up- or downfield shifts are directly 
related to coordination, while larger shifts are brought about by other factors. The 
1
H NMR of 
complexes 3, 4, 14 and 15 all contain a H7 proton with a large upfield shift; this is due to 
strong anisotropic shielding, a result of H7’s close proximity to the centre of an adjacent 
pyridine system. This is further illustrated in the 
1
H NMR spectra of complexes 9-11; no 
large shifts are observed, as the shape of the ligands involved prevent these protons from 
experiencing the same anisotropic shielding.  
 
In each ligand, at least one of the coordinating nitrogens is part of an azole system. Azoles 
are more electron rich than azines like pyridine, and the result of coordinating a more electron 
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rich ligand could be observed in the UV-visible spectra and electrochemical data. In general, 
these complexes absorbed at longer wavelengths than [Ru(bpy)3]
2+
, as the metal based 
HOMO had been raised and the electron rich ligands provided a lower LUMO. This could 
also be seen in the electrochemical data, as when compared to [Ru(bpy)3]
2+
, each complex 
was observed to be both easier to oxidise and harder to reduce.  
 
In summary, the heterocyclic systems examined here all appear to possess similar properties 
when complexed as [Ru(bpy)2(L)]
2+
, relative to [Ru(bpy)3]
2+
. Complexes were easier to 
oxidise, harder to reduce, and absorb light at longer wavelengths, which all point towards the 
electron rich nature of the ligand. Future work on this topic may involve examining ligands 
containing the pyrazolo[1,5-a]pyridine moiety, substituted derivatives, or even ligands 







6.1 General Experimental 
 
NMR spectra were recorded on Agilent 400-MR or Varian INOVA 500 spectrometers with a 
5 mm or 3 mm probe and operating at 400MHz and 500MHz, respectively, for 
1
H and 
100MHz and 125MHz respectively for 
13
C. Spectra recorded in CDCl3 were referenced to an 
internal Me4Si standard, while those recorded in CD3CN were referenced against the 
respective solvent signal (1.94 ppm). 
13
C NMR spectra were referenced against the solvent 
signals; CDCl3 (77.0 ppm) and CD3CN (117.3 ppm). 1D TOCSY and two dimensional 
experiments (COSY, HSQC, HMBC) were performed using standard pulse sequences and 
parameters available with the two spectrometers. Unless otherwise stated the value for the 
chemical shift is given to the centre of the multiplet. 
 
Cyclic voltammetric measurements were made on an EG&G Princeton Model 362 Scanning 
Potentiostat. Measurements were made of acetonitrile solutions containing ca. 1 mM 
complex with 0.1 M tetrabutylammonium tetrafluoroborate as the supporting electrode, using 
a scan rate of 100 mVs
-1
 and a platinum working electrode (area 0.07 cm
-2
), with a silver wire 
reference electrode and a gold wire auxiliary electrode. Ferrocene was used as an internal 
standard and the potentials given in the preceding chapters have been corrected versus the 




) = 0.31 V vs SCE]; the data presented in this 
experimental section are uncorrected (i.e. vs silver wire). Differential pulse voltammetry 
measurements were made on an Autolab PGSTAT302N potentiostat/galvanostat. 
Measurements were made of acetonitrile solutions containing ca. 0.1 mM complex, with 
supporting electrolyte, electrodes and ferrocene reference as above.  
Mass Spectra (ESI) were recorded using a Bruker UHR-TOF MaXis 4G mass spectrometer 
with Dionex UltiMate 3000 UHPLC system. Samples were submitted dissolved in 
67 
acetonitrile. UV-Visible spectra were recorded on a Varian Cary 100 Bio UV-Visible 
spectrophotometer in acetonitrile. Infrared spectra were recorded from solids using a Bruker 
ALPHA FT-IR Spectrometer with Platinum-ATR attachment.  Melting points were 
determined using an Electrothermal melting point apparatus and are uncorrected. The 
Chemistry Department, University of Otago, Dunedin, performed elemental analyses. 
 
Unless otherwise stated, reagents were obtained from commercial sources and used as 


















Following a procedure detailed by Cyransi et al.,
42
 2-
aminopyridine (455 mg, 4.83 mmol), 2-acetylpyridine (0.25 
mL, 2.23 mmol) and I2 (627 mg, 2.47 mmol) were added to a 
pressure tube, and the mixture was stirred at 110°C for 4 
hours. The temperature was subsequently reduced and the mixture continued to stir overnight. 
After cooling to room temperature, 5 mL H2O and 10 mL NaOH (45%) was added. After 
transferring the solution to a beaker, the mixture was heated for a further 2 hours at 100°C. 
After dilution with DCM (25 mL), the solution was neutralised with HCl (10%). DCM 
extraction was followed by an alumina column eluting with 1:1 DCM:petroleum ether. 
1
H 
NMR analysis of the obtained fractions revealed that a mixture of product and 2-
aminopyridine had been recovered. As sufficient pure stocks of this ligand had been 
synthesised by a previous member of the group, further purification was not pursued.  
M.p. 142-144°C. 
ESI/MS: calc m/z for C12H10N3 (MH
+
) 196.0869; found 196.0870. 
1
H NMR (400 MHz, CD3 N): δ ppm 6.85 (1 H, t, J = 6.6 Hz, H5), 7.20 - 7.30 (2 H, m, H6, 
H5’), 7.54 (1 H, d, J = 9.0 Hz, H7), 7.82 (1 H, td, J = 7.6, 1.5 Hz, H4’), 8.15 (1 H, d, J = 8.2 
Hz, H3’), 8.30 (1 H, s, H3), 8.34 (1 H, d, J = 7.0 Hz, H4), 8.58 (1 H, d, J = 4.7 Hz, H6’).
 
1
H NMR (400 MHz, CDCl3): δ ppm 6.81 (1 H, t, J = 6.8 Hz, H5), 7.17 - 7.25 (2 H, m, H6, 
H5’), 7.65 (1 H, d, J = 9.0 Hz, H7), 7.79 (1 H, td, J = 7.6, 1.5 Hz, H4’), 8.16 (1 H, d, J = 7.0 
Hz, H4), 8.21 (1 H, d, J = 8.2 Hz, H3’), 8.26 (1 H, s, H3), 8.62 (1 H, d, J = 4.7 Hz, H6’). 
13
C NMR (100 MHz, CDCl3): δ ppm 110.9  3; 112.8  5; 117.8  7; 120.5  3’; 122.7  5’; 
125.1  6; 126.0  4; 136.9  4’; 145.5  7a; 145.6  2; 149.4  6’; 152.8  2’. 
IR: ν cm
-1





2-Aminopyridine (0.94 g, 0.01 mol) and 1,4-dibromo-2,3-























mL) and stirred at room temperature over a weekend. The solution was reduced in vacuo and 
redissolved in water, before being basified with NaHCO3. After extracting with EtOAc and 
washing with brine, the product was added to an alumina column eluting with EtOAc. The 
resulting fractions contained both 2-aminopyridine and product, and while reducing the 
volume in vacuo the desired product precipitated. Yield 14.2 mg (1%) 
M.p. >300°C. 
ESI/MS: calc m/z for C14H11N4 (MH
+
) 235.0978; found 235.0976. 
1
H NMR (400 MHz, CD3 N): δ ppm 6.83 (2 H, t, J = 6.8 Hz, H5), 7.22 (2 H, t, J = 7.8 Hz, 
H6), 7.51 (2 H, d, J = 9.0 Hz, H7), 8.15 (2 H, s, H3), 8.33 (2 H, d, J = 7.0 Hz, H4). 
1
H NMR (400 MHz, CDCl3): δ ppm 6.82 (2 H, t, J = 7.0 Hz, H5), 7.22 (2 H, t, J = 7.8 Hz, 
H6), 7.65 (2 H, d, J = 9.0 Hz, H7), 8.18 (2 H, d, J = 6.6 Hz, H4), 8.24 (2 H, s, H3). 
13
C NMR (100 MHz, CDCl3): δ ppm 110.0 C3; 112.7 C5; 117.1 C7; 125.3 C6; 125.99 C4; 
140.1 C2; 145.4 C7a.  
IR: ν cm
-1





Following a procedure detailed by Grigg et al.,
72
 di(2-
pyridyl)ketone (0.686 g, 378 mmol) and glycine (0.288 g, 3.8 
mmol) were added to a solution of methanol containing a few 
drops of glacial acetic acid. The reaction mixture was refluxed for 
24 hours, and the solvent was subsequently removed in vacuo. 
The resulting residue was subjected to column chromatography (silica, EtOAc). Yield 28.7 
mg (39%). 
M.p. 106-109°C. 
ESI/MS: calc m/z for C12H10N3 (MH
+
) 196.0869; found 196.0876.  
1
H NMR (400 MHz, CD3 N): δ ppm 6.71 (1 H, t, J = 6.8 Hz, H5), 6.97 (1 H, dd, J = 8.8, 6.8 
Hz, H6), 7.12 (1 H, dd, J = 6.8, 5.2 Hz, H5’), 7.75 (1 H, td, J = 8.2, 1.0 Hz, H4’), 8.11 (1 H, 
d, J = 7.8 Hz, H3’), 8.16 (1 H, d, J = 7.0 Hz, H4), 8.22 (1 H, s, H3), 8.54 (1 H, d, J = 9.3 Hz, 
H7), 8.57 (1 H, d, J = 4.3 Hz, H6’). 
1
H NMR (400 MHz, CDCl3): δ ppm 6.65 (1 H, t, J = 7.0 Hz, H5), 6.90 (1 H, t, J = 8.2 Hz, 
H6), 7.08 (1 H, ddd, J = 7.4, 5.0, 1.1 Hz, H5’), 7.71 (1 H, td, J = 7.7, 1.7 Hz, H4’), 7.95 (1 H, 





















C NMR (100 MHz, CDCl3): δ ppm 113.7  5; 119.6  3’; 120.4  5’; 121.2  6; 121.5  7; 
122.3  4; 129.0  7a; 130.2  1; 136.3  4’; 148.9  6’; 154.9  2’. 
IR: ν cm
-1





Attempted synthesis  
2,2'-Pyridil (403 mg, 1.90 mmol) and glycine (441 mg, 5.87 
mmol) were added to a solution of methanol (20 mL) containing a 
few drops of glacial acetic acid, and refluxed overnight. After 
cooling to room temperature, the solution was filtered to remove unreacted glycine, and was 
run through a silica column eluting EtOAc. 
1
H NMR and ESI/MS was used to determine that 
there was none of the desired product present. 
 
2,2'-Pyridil (1.06 g, 5 mmol), formaldehyde (0.60 g) and ammonium acetate (1.93 g, 25 
mmol), were added to glacial acetic acid (50 mL) and refluxed under nitrogen for 5 hours. 
After cooling, the reaction mixture was neutralised by addition of NaCl and NaHCO3. The 
mixture was extracted with DCM, and dried in vacuo. The solid was further extracted with 
petroleum ether. 
1
H NMR and ESI/MS of the resulting oil indicated that there was none of 





Ligand 7 was received with gratitude from Dr Chris Richardson. 
M.p. 114-116°C. 
ESI/MS: calc m/z for C12H10N3 (MH
+
) 196.0869; found 196.0869. 
1
H NMR (400 MHz, CD3 N): δ ppm 6.82 (1 H, t, J = 6.8 Hz, 
H5), 6.93 (1 H, dd, J = 9.0, 6.6 Hz, H6), 7.28 (1 H, dd, J = 6.8, 
5.2 Hz, H5’), 7.57 (1 H, s, H1), 7.63 (1 H, d, J = 9.0 Hz, H7), 7.85 (1 H, t, J = 8.2 Hz, H4’), 
8.31 (1 H, d, J = 8.2 Hz, H3’), 8.66 (1 H, d, J = 5.0 Hz, H6’), 9.95 (1 H, d, J = 7.4 Hz, H4). 
1
H NMR (400 MHz, CDCl3): δ ppm 6.74 (1 H, t, J = 7.0 Hz, H5), 6.87 (1 H, ddd, J = 9.0, 
























7.60 (1 H, s, H1), 7.78 (1 H, td, J = 7.8, 1.9 Hz, H4’), 8.36 (1 H, d, J = 7.8 Hz, H3’), 8.64 (1 
H, d, J = 4.7 Hz, H6’), 9.97 (1 H, dd, J = 7.4, 0.7 Hz, H4). 
13
C NMR (100 MHz, CDCl3): δ ppm 113.6  5; 118.0  7; 120.2  6; 120.8  1; 121.6  5’; 
121.8  3’; 126.0  4; 132.9  7a; 135.3  3; 136.5  4’; 148.1  6’; 151.0  2’. 
IR: ν cm
-1





Ligand 8 was received with gratitude from Dr Chris Richardson.  
M.p. 160-162°C. 
ESI/MS: calc m/z for C14H11N4 (MH
+
) 235.0978; found 235.0974. 
1
H NMR (400 MHz, CD3CN): δ ppm 6.87 (2 H, t, J = 6.6 Hz, 
H5), 6.96 (2 H, t, J = 7.0 Hz, H6), 7.65 (2 H, s, H1), 7.67 (2 H, d, J = 9.3 Hz, H7), 9.82 (2 H, 
d, J = 7.8 Hz, H4). 
13
C NMR (100 MHz, CD3CN): δ ppm 113.4  5; 118.0  7; 119.8  6; 120.2  1; 124.8  4; 
C3, C7a not recorded. 
IR: ν cm
-1





1,2-Diaminopyridinium tosylate (1.41 g, 5.00 mmol) and 2-
pyridinecarboxaldehyde (1.07g, 10 mmol) were added to a 
solution of methanol (50 mL) containing potassium 
hydroxide (50 mmol). The reaction was stirred at room 
temperature and monitored by TLC. Once complete, the reaction mixture was evaporated 
under reduced pressure, before being redissolved in water (100 mL) and extracted with DCM 
(40 mL). After further washing the organic layer with water and brine, the product was dried 
over Na2SO4 and purified on an alumina plug eluting with 1:1 EtOAc:DCM. Yield 0.898 g 
(91%). 
M.p. 166-167°C. 
ESI/MS: calc m/z for C11H9N4 (MH
+

























H NMR (400 MHz, CD3 N): δ ppm 7.15 (1 H, t, J = 7.0 Hz, H5), 7.44 (1 H, dd, J = 7.4, 4.7 
Hz, H5’), 7.63 (1 H, t, J = 7.4 Hz, H6), 7.79 (1 H, d, J = 9.0 Hz, H7), 7.91 (1 H, td, J = 7.6, 
1.5 Hz, H4’), 8.31 (1 H, d, J = 8.2 Hz, H3’), 8.74 (2 H, m, H4, H6’).
 
1
H NMR (400 MHz, CDCl3): δ ppm 7.06 (1 H, td, J = 6.8, 1.1 Hz, H5), 7.39 (1 H, ddd, J = 
7.4, 4.7, 1.1 Hz, H5’), 7.55 (1 H, ddd, J = 7.0, 5.4, 1.5 Hz, H6), 7.81 (1 H, d, J = 9.0 Hz, H7), 
7.86 (1 H, td, J = 7.7, 1.7 Hz, H4’), 8.34 (1 H, d, J = 7.8 Hz, H3’), 8.68 (1 H, d, J = 6.6 Hz, 
H4), 8.81 (1 H, d, J = 5.1 Hz, H6’) 
13
C NMR (100 MHz, CDCl3): δ ppm 114.26 C5; 116.9 C7; 122.6 C3'; 124.5 C5'; 128.7 C4; 
129.8 C6; 136.8 C4'; 149.7 C2'; 150.2 C6'; 151.7 C7a; 163.5 C2. 
IR: ν cm
-1





Sodium ethoxide (0.55 g, 8.08 mmol) was dissolved in 
25 mL EtOH. 1,2-Diaminopyridinium tosylate (1.51 g, 
5.37 mmol) was added to the solution and stirred for five 
minutes, at which point diethyl oxalate (0.40 mL, 2.66 mmol) was added and the mixture was 
brought to reflux for five hours. Water (70 mL) was added to the hot solution, and the 
mixture was left to crystallise overnight. The crystals were filtered and washed with water, 
before being dried in vacuo. Yield 0.27 g (43%). 
M.p. >300°C. 
ESI/MS: calc m/z for C12H9N6 (MH
+
) 237.0883; found 237.0880. 
1
H NMR (400 MHz, CD3 N): δ ppm 7.19 (2 H, t, J = 6.8 Hz, H5), 7.67 (2 H, t, J = 7.8 Hz, 
H6), 7.84 (2 H, d, J = 9.0 Hz, H7), 8.79 (2 H, d, J = 6.6 Hz, H4). 
1
H NMR (400 MHz, CDCl3): δ ppm 7.11 (2 H, t, J = 6.8 Hz, H5), 7.59 (2 H, t, J = 7.8 Hz, 
H6), 7.87 (2 H, d, J = 9.0 Hz, H7), 8.71 (2 H, d, J = 7.0 Hz, H4). 
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2-(Pyridin-2-yl)imidazo[1,2-a]pyridine (1) (26 mg, 0.13mmol)  and Ru(bpy)2Cl2 (63 mg, 0.13 
mmol) were refluxed in 3:1 ethanol:water (8 mL) overnight. After cooling, the reaction 
mixture was concentrated to dryness in vacuo. The residue was redissolved in the minimum 
amount of water, filtered to remove unreacted ligand, and the complex was precipitated out 
by the addition of an aqueous solution of KPF6. The aqueous solution was extracted with 
DCM, dried over Na2SO4, and loaded onto a column of alumina eluting 95:5 DCM:MeOH. 
The fractions were dried in vacuo. Yield 110 mg (95%). 
M.p. >300°C. 
EA: found C:44.93, H:3.56, N:9.94. Calculated for [(bpy)2Ru(L)](PF6)2·2(C3H6O) C:44.98, 
H:3.68, N:9.66. 
ESI/MS: calc m/z for C32H25N7Ru (M
2+
) 304.5606; found 304.5609 
1
H NMR (400 MHz, CD3CN): δ ppm 5.59 (1 H, d, J = 9.0 Hz, H7), 7.00 (1 H, t, J = 7.0 Hz, 
H5), 7.11 (1 H, t, J = 7.8 Hz, H6), 7.25 (1 H, t, J = 7.0 Hz, H5’), 7.30 - 7.45 (4 H, m, bpy 
H5), 7.55 (1 H, d, J = 5.4 Hz, H6’), 7.75 (1 H, d, J = 5.4 Hz, bpy H6), 7.86 (1 H, d, J = 5.4 
Hz, bpy H6), 7.88 - 7.93 (2 H, m, bpy H6), 7.93 - 8.11 (5 H, m, H4’, bpy H4), 8.23 (1 H, d, J 
= 8.2 Hz, H3’), 8.43 (2 H, d, J = 8.2 Hz, H4, bpy H3), 8.49 (3 H, d, J = 8.2 Hz, bpy H3), 8.65 
(1 H, s, H3) 
13
C NMR (100 MHz, CD3CN) δ ppm 112.9 C7; 114.1 C3; 114.8 C5; 122.3  6’; 123.9, 
124.01, 124.04, 124.2 bpy  6; 125.6  4’; 127.25, 127.29, 127.4, 127.5 bpy C4; 129.3 C4; 
129.6 C6; 137.1, 137.28, 137.33, 137.6, 137.8 bpy  5/ 5’; 143.5  2; 146.3  7a; 151.4  3’; 
151.6, 152.1, 152.2, 152.3 bpy  3; 153.7  2’; 157.18, 157.20, 157.95, 158.04 bpy C2. 
IR: ν cm
-1
 1708, 1605, 1464, 1445, 1223, 1122, 828, 759, 554, 422 
UV-Vis (CH3CN) 




, log ε = 3.904 




, log ε = 3.883 




, log ε = 4.075 




, log ε = 4.693 
74 




, log ε = 4.354 











 +1.12(78) V; E
0
red -1.34(81) V; E
0











2,2'-Biimidazo[1,2-a]pyridine (2) (9.90 mg, 0.042 mmol)  and Ru(bpy)2Cl2 (21.50 mg, 0.044 
mmol) in ethylene glycol (8 mL) were reacted via microwave irradiation (450 W, 3x2 
minutes). After cooling, the solution was diluted with distilled water and filtered through a 
Celite plug. The complex was precipitated by the addition of an aqueous solution of KPF6, 
and the settled precipitate was filtered. The complex was recrystallised by the addition of 
excess diethyl ether to an acetonitrile solution. Yield 26.1 mg (66%). 
M.p. >300°C. 
EA: found C:41.03, H:2.91, N:11.20. Calculated for [(bpy)2Ru(L)](PF6)2·3H2O C:41.18, 
H:3.25, N:11.30. 
ESI/MS: calc m/z for C34H26N8Ru (M
2+
) 324.0661; found 324.0665  
1
H NMR (400 MHz, CD3CN): δ ppm 5.48 (2 H, d, J = 9.0 Hz, H7), 6.95 (2 H, t, J = 6.6 Hz, 
H5), 7.06 (2 H, t, J = 7.8 Hz, H6), 7.30 (2 H, t, J = 6.8 Hz, bpy H5), 7.40 (2 H, t, J = 6.6 Hz, 
bpy H5), 7.89 - 7.99 (6 H, m, bpy H6, bpy H4, bpy H6), 8.06 (2 H, t, J = 8.0 Hz, bpy H4), 
8.38 - 8.45 (6 H, m, H4, bpy H3, H3), 8.48 (2 H, d, J = 8.2 Hz, bpy H3) 
13
C NMR (100 MHz, CD3CN): δ ppm 111.1 C3; 112.6 C7; 114.3 C5; 123.7, 124.0 bpy C3; 
127.1, 127.3 bpy C5; 128.9 C6; 129.0 C4; 136.7, 137.2 bpy C4; 138.7 C2; 146.1 C7a; 152.1, 
152.6 bpy C6; 157.4, 158.9 bpy C2. 
IR: ν cm
-1
 1638, 1510, 1464, 1445, 1422, 1316, 831, 758, 556, 423 
UV-Vis (CH3CN) 




, log ε = 3.910 




, log ε = 3.731 




, log ε = 3.924 




, log ε = 4.245 




, log ε = 4.780 




, log ε = 4.559 
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, log ε = 4.638 











 +895(80) mV; E
0
red -1.50(70) V; E
0











1-(Pyridin-2-yl)imidazo[1,5-a]pyridine (5) (24.7 mg, 0.127 mmol)  and Ru(bpy)2Cl2 (62.4 
mg, 1.29 mmol) were refluxed in 3:1 ethanol:water (8 mL) overnight. After cooling, the 
reaction mixture was concentrated to dryness in vacuo. The residue was redissolved in the 
minimum amount of water, filtered to remove unreacted ligand, and the complex was 
precipitated out by the addition of an aqueous solution of KPF6. The aqueous solution was 
extracted with DCM, dried over Na2SO4, and loaded onto a column of alumina eluting with 
95:5 DCM:MeOH. The fractions were dried in vacuo. Yield 102 mg (90%). 
M.p. ~215-218°C. 
EA: found C:42.75, H:2.97, N:10.95. Calculated for [(bpy)2Ru(L)](PF6)2 C:42.77, H:2.80, 
N:10.91. 
ESI/MS: calc m/z for C32H25N7Ru (M
2+
) 304.5606; found 304.5610 
1
H NMR (400 MHz, CD3 N): δ ppm 6.97 (1 H, t, J = 7.2 Hz, H5), 7.10 (1 H, t, J = 6.4 Hz, 
H5’), 7.31 - 7.42 (5 H, m, H6, bpy H5), 7.53 (1 H, d, J = 5.8 Hz, H6’), 7.80 (1 H, d, J = 5.8 
Hz, bpy H6), 7.82 - 7.86 (2 H, m, bpy H6), 7.87 (1 H, s, H3), 7.88 - 7.95 (2 H, m, bpy H6, 
H4’), 7.98 - 8.07 (4 H, m, bpy H4), 8.08 - 8.13 (2 H, m, H7, H4), 8.16 (1 H, d, J = 8.2 Hz, 
H3’), 8.43 - 8.53 (4 H, m, bpy H3) 
13
C NMR (100 MHz, CD3 N): δ ppm 115.0  5; 116.2  7; 120.3  3’ 123.0  5’; 123.7, 
123.8, 123.9, 124.1 bpy C3; 124.6 C4; 126.2 C6; 126.9, 127.1, 127.28, 127.34 bpy C5; 128.9 
C1; 130.2 C7a; 137.24, 137.28, 137.31, 137.5  4’/bpy H4; 151.2 H6’; 151.7, 151.8, 151.9, 
152.2 bpy  6; 154.4  2’; 157.1, 157.2, 157.5, 157.7 bpy  2;  3 not recorded 
IR: ν cm
-1
 1603, 1528, 1445, 1259, 1092, 1017, 821, 758, 554, 423 
UV-Vis (CH3CN) 




, log ε = 3.999 




, log ε = 3.972 




, log ε = 4.167 
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, log ε = 4.174 




, log ε = 4.747 




, log ε = 4.330 











 +1.16(90) V; E
0
red -1.41(102) V; E
0











3-(Pyridin-2-yl)imidazo[1,5-a]pyridine (7) (12.8 mg, 0.0656 mmol)  and Ru(bpy)2Cl2 (32.1 
mg, 0.0663 mmol) in ethylene glycol (8 mL) were reacted via microwave irradiation (450 W, 
3x2 minutes). After cooling, the solution was diluted with distilled water and filtered through 
a Celite plug. The complex was precipitated by the addition of an aqueous solution of KPF6, 
and the precipitate was filtered. The complex was recrystallised by the addition of excess 
diethyl ether to an acetonitrile solution. Yield 34.6 mg (58%). 
M.p. ~212-215°C. 
EA: found C:40.35, H:2.68, N:10.37. Calculated for [(bpy)2Ru(L)](PF6)2·3H2O C:40.35, 
H:3.28, N:10.29. 
ESI/MS: calc m/z for C32H25N7Ru (M
2+
) 304.5606; found 304.5603 
1
H NMR (400 MHz, CD3CN): δ ppm 7.03 (1 H, s, H1), 7.15 - 7.26 (3 H, m, H5, H6’, H6), 
7.30 - 7.43 (4 H, m, bpy H5), 7.63 (1 H, d, J = 9.0 Hz, H7), 7.68 - 7.74 (2 H, m, H6’, bpy 
H6), 7.79 (1 H, d, J = 5.4 Hz, bpy H6), 7.83 (2 H, d, J = 5.4 Hz, bpy H6), 7.97 - 8.09 (5 H, m, 
bpy H4, H4’), 8.31 (1 H, d, J = 8.6 Hz, H3’), 8.43 - 8.52 (4 H, m, bpy H3), 8.83 (1 H, d, J = 
7.0 Hz, H4) 
13
C NMR (100 MHz, CD3CN-d3) δ ppm 116.8  5; 118.1  7; 120.7  3’; 121.9  1; 123.4, 
123.5, 123.7, 123.8, 124.0, 124.2, 124.3  4/ 6/ 5’/bpy  3; 127.0, 127.2, 127.36, 127.39 bpy 
C5; 135.2 C7a; 137.33, 137.38, 137.41, 137.6 bpy  4/ 4’; 149.4  2’; 151.8, 152.05, 152.14, 
152.4 bpy  6/ 6’; 157.0, 157.4, 157.5 bpy  2;  3 not recorded. 
IR: ν cm
-1
 1602, 1479, 1444, 1422, 1370, 827, 763, 687, 556, 422. 
UV-Vis (CH3CN) 




, log ε = 4.065 




, log ε = 4.059 
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, log ε = 4.160 




, log ε = 4.193 




, log ε = 4.323 




, log ε = 4.754 




, log ε = 4.327 











 +1.07(84) V; E
0
red -1.50(83) V; E
0











3,3'-Biimidazo[1,5-a]pyridine (8) (15.2 mg, 0.034 mmol)  and Ru(bpy)2Cl2 (32.1 mg, 0.062 
mmol) in ethylene glycol (8 mL) were reacted via microwave irradiation (450 W, 4x2 
minutes). After cooling, the solution was diluted with distilled water and filtered through a 
Celite plug. The complex was precipitated by the addition of an aqueous solution of KPF6, 
and the precipitate was filtered. The complex was recrystallised by the addition of excess 
diethyl ether to an acetonitrile solution, and subjected to column chromatography (alumina, 
DCM:MeOH 95:5). Yield 5.2 mg (16%). 
M.p. >300°C. 
ESI/MS: calc m/z for C34H26N8Ru (M
2+
) 324.0661; found 324.0660 
1
H NMR (400 MHz, CD3CN): δ ppm 6.96 (2 H, s, H1), 6.99 - 7.10 (4 H, m, H5, H6), 7.33 (2 
H, t, J = 6.2 Hz, bpy H5), 7.38 (2 H, t, J = 6.2 Hz, bpy H5), 7.51 (2 H, d, J = 8.2 Hz, H7), 
7.84 (2 H, d, J = 5.0 Hz, bpy H6), 7.88 (2 H, d, J = 5.0 Hz, bpy H6), 7.98 (2 H, t, J = 7.8 Hz, 
bpy H4), 8.03 (2 H, t, J = 7.8 Hz, bpy H4), 8.45 (1 H, d, J = 8.2 Hz, bpy H3), 8.48 (1 H, d, J 
= 7.8 Hz, bpy H3), 8.61 (1 H, d, J = 6.6 Hz, H4) 
13
C NMR (100 MHz, CD3CN): δ ppm 116.0  5; 118.1  7; 121.9  6; 122.3  1; 123.5, 123.7 
bpy C3; 124.5 C4; 126.8, 127.1 bpy C5; 133.7 C7a; 137.0 bpy C4; 152.2, 152.3 bpy C6; C3, 
bpy C2 not recorded. 
IR: ν cm
-1
 1602, 1445, 1422, 1363, 1242, 829, 759, 728, 555, 420 
UV-Vis (CH3CN) 




, log ε = 3.964 




, log ε = 4.049 
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, log ε = 4.302 











 +987 mV; E
0
red -1.36 V; E
0










2-(Pyridin-2-yl)[1,2,4]triazolo[1,5-a]pyridine (12) (12.5 mg, 0.066 mmol)  and Ru(bpy)2Cl2 
(32.1 mg, 0.063 mmol) in ethylene glycol (8 mL) were reacted via microwave irradiation 
(450 W, 3x2 minutes). After cooling, the solution was diluted with distilled water and filtered 
through a Celite plug. The complex was precipitated by the addition of an aqueous solution of 
KPF6, and the precipitate was filtered. The complex was recrystallised by the addition of 
excess diethyl ether to an acetonitrile solution. Yield 38.8 mg (66%). 
M.p. >300°C. 
EA: found C:40.67, H:2.63, N:12.10. Calculated for [(bpy)2Ru(L)](PF6)2·H2O C:40.58, 
H:2.86, N:12.21. 
ESI/MS: calc m/z for C31H24N8Ru (M
2+
) 305.0582; found 305.0578 
1
H NMR (500 MHz, CD3CN): δ ppm 5.88 (1 H, d, J = 9.0 Hz, H7), 7.28 - 7.48 (6 H, m, H5, 
bpy H5, H5’), 7.53 (1 H, t, J = 8.0 Hz, H6), 7.68 (1 H, d, J = 5.6 Hz, H6’), 7.76 (1 H, d, J = 
5.6 Hz, bpy H6), 7.85 (1 H, d, J = 4.8 Hz, bpy H6), 7.91 (1 H, d, J = 5.6 Hz, bpy H6), 8.00 (1 
H, t, J = 7.8 Hz, bpy H4), 8.02 - 8.14 (6 H, m, bpy H4, bpy H6, H4'), 8.43 (1 H, d, J = 8.3 Hz, 
bpy H3), 8.46 - 8.54 (4 H, m, H3’, bpy H3), 8.83 (1 H, d, J = 6.8 Hz, H4). 
13
C NMR (125 MHz, CD3CN): δ ppm 112.9 C7; 117.1 C5; 123.90, 124.0, 124.1, 124.29, 
124.32  3’/bpy  3; 127.3, 127.4, 127.5, 127.7, 128.3  5’/bpy  5; 131.3  4; 134.2  6; 
137.48, 137.54, 137.6, 138.0, 138.5  4’/bpy  4; 149.5  2’; 151.0  7a; 151.7, 151.9, 152.3, 
152.5, 152.6  6’/bpy  6; 157.07,157.12, 158.0, 158.1 bpy C2; C2 not recorded. 
IR: ν cm
-1
 1638, 1605, 1448, 1427, 1330, 1160, 831, 757, 556, 421 
UV-Vis (CH3CN) 




, log ε = 3.991 




, log ε = 3.963 




, log ε = 4.765 











 +1.28(90) V; E
0











2,2'-Bi[1,2,4]triazolo[1,5-a]pyridine (13) (15.67 mg, 0.066 mmol)  and Ru(bpy)2Cl2 (31.31 
mg, 0.065 mmol) in ethylene glycol (8 mL) were reacted via microwave irradiation (450 W, 
3x2 minutes). After cooling, the solution was diluted with distilled water and filtered through 
a Celite plug. The complex was precipitated by the addition of an aqueous solution of KPF6, 
and the precipitate was filtered. The complex was recrystallised by the addition of excess 
diethyl ether to an acetonitrile solution. Yield 41.95 mg (69%). 
M.p. >300°C. 
EA: found C: 40.32, H: 2.54, N: 14.46. Calculated for [(bpy)2Ru(L)](PF6)2·H2O C: 40.14, H: 
2.74, N: 14.63. 
ESI/MS: calc m/z for C32H24N10Ru (M
2+
) 325.0613; found 325.0611. 
1
H NMR (500 MHz, CD3CN): δ ppm 5.80 (2 H, d, J = 9.0 Hz, H7), 7.32 - 7.37 (4 H, m, H5, 
bpy H5), 7.43 (2 H, t, J = 6.6 Hz, bpy H5), 7.56 (2 H, t, J = 8.0 Hz, H6), 7.93 (2 H, d, J = 5.8 
Hz, bpy H6), 7.99 (2 H, t, J = 7.7 Hz, bpy H4), 8.07 - 8.15 (4 H, m, bpy H4, bpy H6), 8.43 (2 
H, d, J = 8.3 Hz, bpy H3), 8.50 (2 H, d, J = 8.3 Hz, bpy H3), 8.87 (2 H, d, J = 6.8 Hz, H4). 
13
C NMR (125 MHz, CD3CN): δ ppm 112.9 C7; 117.5 C5; 123.8, 124.1 bpy C3; 127.3, 127.5 
bpy C5; 131.6 C4; 134.5 C6; 137.3, 137.8 bpy C4; 151.0 C7a; 152.8, 153.0 bpy C6; 157.2, 
158.9 bpy C2; C2 not recorded. 
IR: ν cm
-1
 1638, 1517, 1446, 1386, 1347, 1261, 828, 758, 555, 429. 
UV-Vis (CH3CN) 




, log ε = 3.933 




, log ε = 3.823 




, log ε = 3.997 




, log ε = 4.750 











 +1.22(83) V; E
0
red -1.34(81) V; E
0













Tables 7.1 and 7.2 list crystal data and X-ray experimental details for the six crystal 
structures discussed in this thesis. Selected bond lengths and angles are listed in the 
discussion of the structures, and the remaining distances and angles, as well as atom 
coordinates, anisotropic displacement parameters and hydrogen atom coordinates, are 
available from the Department of Chemistry, University of Canterbury. 
All measurements were made on an Oxford-Agilent SuperNova diffractometer with focused 
microsource  u Kα [λ = 1.54184 Å] or Mo Kα [0.71073 Å] radiation, and ATLAS   D area 
detector. CrysAlisPro was used for the data collection and data processing. The structures 
were solved by direct methods using SHELXS
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all data. The latest version Olex2
107
 was used for visualisation. The hydrogen atoms were 
included in calculated positions and assigned isotropic displacement parameters 1.3 times the 
isotropic equivalent of their carrier atoms. Graphical presentation of crystallographic data 





Table 7.1 Crystal Data and X-ray Experimental Details for 3, 4 and 9 
Compound 3 4 9 
Empirical formula  C36.5H32.5F12N7O1.5P2Ru  C74.3H64.6F24N16O2.1P4Ru2  C32H25F12N7P2Ru  
Formula weight  984.20  1997.24  898.60  
Temperature (K)  120  120  120  
Crystal system  Monoclinic  Monoclinic  Monoclinic  
Space group  C2/c  C2/c  P21/n  
Unit cell dimensions: a/Å  22.8380(4)  24.1893(4)  10.739(2)  
Unit cell dimensions: b/Å  14.3814(2)  13.8139(2)  19.539(4)  
Unit cell dimensions: c/Å  24.2375(4)  24.8135(4)  15.769(3)  
Unit cell dimensions: α/°  90  90  90  
Unit cell dimensions: β/°  91.0244(16)  96.4497(16)  94.94(3)  
Unit cell dimensions: γ/°  90  90  90  
Volume (Å
3
)  7959.4(2)  8238.9(2)  3296.7(11)  
Z  8  4  4  
Density (calculated) (mg/mm
3
)  1.643  1.610  1.810  
μ/mm
-1
 4.845  4.690  0.679  
F(000)  3956 4013 1792 
Crystal size (mm
3
)  0.32 × 0.26 × 0.19  0.22 × 0.10 × 0.09  0.42 × 0.05 × 0.04  
Radiation   uKα (λ = 1.54184)   uKα (λ = 1.54184)  MoKα (λ = 0.71073)  
Theta range for data collection (°) 7.2 to 141.9°  7.1 to 133.9°  3.3 to 52.7°  
Reflections collected  27189  15482  22904  
Independent reflections [R(int)] 7661 (0.0359)  7358 (0.0281)  6646 (0.0345)  
Data / restraints / parameters  7661 / 0 / 564  7358 / 0 / 572  6646 / 0 / 487  
Goodness-of-fit on F
2
  1.091  1.067  1.050  
R1 [I>=2σ (I)]  0.0735  0.0446  0.0377  
wR2 [all data]  0.1730  0.1308  0.1003  
82 
Table 7.2 Crystal Data and X-ray Experimental Details for 14, 15 and 16 
Compound 14 15 16 
Empirical formula  C37H36F12N8O2P2Ru  C38H36F12N10O2P2Ru  C34H24F12N14P2Ru  
Formula weight  1015.75  1055.78  1019.68  
Temperature (K)  120  120  120  
Crystal system  Triclinic  Monoclinic  Monoclinic  
Space group  P-1  P21/n  C2/c  
Unit cell dimensions: a/Å  12.2146(4)  10.20205(13)  25.0157(4)  
Unit cell dimensions: b/Å  13.2552(5)  10.01137(13)  14.16880(19)  
Unit cell dimensions: c/Å  14.3847(5)  41.2557(7)  14.0775(3)  
Unit cell dimensions: α/°  63.309(3)  90  90  
Unit cell dimensions: β/°  81.771(3)  96.7094(14)  102.3682(17)  
Unit cell dimensions: γ/°  88.771(3)  90  90  
Volume (Å
3
)  2056.97(13)  4184.85(11)  4873.86(14)  
Z  2  4  4  
Density (calculated) (mg/mm
3
)  1.640  1.676  1.390  
μ/mm
-1
 4.723  4.685  3.999  
F(000)  1024 2128 2032 
Crystal size (mm
3
)  0.18 × 0.15 × 0.05  0.50 × 0.09 × 0.02 0.19 × 0.10 × 0.10 
Radiation   uKα (λ = 1.54184)   uKα (λ = 1.54184)   uKα (λ = 1.54184)  
Theta range for data collection (°) 6.9 to 147.4°  8.6 to 133.9°  7.2 to 147.9°  
Reflections collected  39335  26405  42488  
Independent reflections [R(int)] 8212 (0.0836)  7439 (0.0358)  4918 (0.0525)  
Data / restraints / parameters  8212 / 0/ 563  7439 / 6 / 590  4918 / 0 / 285  
Goodness-of-fit on F
2
  1.181  1.143  1.127  
Final R indexes [I>=2σ (I)]  R1 = 0.0546, wR2 = 0.1610  R1 = 0.0475, wR2 = 0.1126  R1 = 0.0777, wR2 = 0.1891  
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